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BACKGROUND: Multiple sclerosis (MS) is an immune-mediated disease of the central nervous 
system that results in physiological deconditioning and walking impairments. High-intensity 
interval training exercise (HIIT) has induced significant improvements in physiological 
conditioning in healthy and clinical populations. However, the effects of engaging in HIIT on 
cardiorespiratory functioning, gait, and walking performance in persons with MS who have 
mobility impairments are relatively unknown.  
OBJECTIVES: To examine the effects of single sessions of HIIT and the Canadian Physical 
Activity Guidelines (CPAG) for aerobic exercise using recumbent stepping on physiological and 
functional outcomes in persons with MS. 
METHODS: 20 participants with mild-to-moderate MS underwent HIIT and CPAG exercise 
bouts. The HIIT bout included 10 cycles of one minute intervals at the wattage associated with 
90% VO2peak followed by one-minute recovery intervals at 15W, totaling 20 minutes in length. 
The CPAG bout consisted of 20 minutes at the wattage associated with 50-60% VO2peak. All 
exercise sessions were preceded and concluded by a 5-minute warm-up and cool-down, 
respectively. Physiological (i.e., power output, oxygen consumption, carbon dioxide expiration, 
respiratory exchange ratio, ventilation, heart rate, and core temperature) and perceived training 
session tolerance (i.e., ratings of perceived exertion, arm pain, and leg pain) measures were 
collected within session, and functional (i.e., walking speed, spatiotemporal aspects of gait, and 
cognition), mood, and enjoyment measures were collected pre-, immediately-post, and 30-
minutes post-exercise. Significant differences between the HIIT and CPAG protocols were 
determined using a repeated-measures, two-factor analysis of variance with condition (HIIT, 
CPAG) and time as within subject factors. 
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RESULTS: The data revealed significant condition u time interactions for all physiological 
measures, ratings of perceived exertion, and leg pain, with differential patterns evident over time 
for the HIIT versus CPAG conditions (p < .05). The main effect of condition was significant for 
all physiological outcomes, except core temperature, with the HIIT condition inducing 
significantly higher values for all physiological outcomes than the CPAG condition (p < .05). 
Core temperature increased during both conditions, but did not significantly differ by condition 
(p > .05). There were no significant condition u time interactions or main effects of condition on 
arm pain, walking speed, spatiotemporal aspects of gait, or mood (p > .05). The main effect of 
time was significant for all physiological measures, perceived training session tolerance 
measures, all spatiotemporal aspects of gait, cognition, and mood (p < .05), except for anger and 
depression (p > .05). Walking speed did not significantly differ by time (p > .05). Participants 
enjoyed the HIIT and CPAG exercise sessions similarly (p > .05).  
CONCLUSIONS: The data indicate that HIIT exercise taxes the cardiorespiratory system 
significantly more than CPAG exercise, yet without sustained deleterious effects on core 
temperature, walking, gait, cognition, mood, or enjoyment in persons with MS. This has 
important implications for informing an evidence-based exercise prescription that is appropriate 
for improving physiological conditioning for a randomized control trial in persons with MS who 
have walking impairments.   
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Multiple sclerosis (MS) initially manifests itself as multi-focal areas of inflammation that 
initiate demyelination and the transection of axons1. This immune-mediated neurodegenerative 
disease of the central nervous system (CNS) is estimated to affect 2.5 million people worldwide 
and 400,000 people in the Unites States alone1–3. Optic neuritis, motor symptoms (i.e., heaviness, 
stiffness, weakness, pain or paralysis), sensory symptoms (i.e., tingling, burning, a pins-and-
needles sensation, or complete loss of sensation), and neuropsychiatric abnormalities (i.e., 
declines in language skills, memory, and intellectual function) are the clinical manifestations of 
MS4. Walking dysfunction is particularly prevalent with as many as 75% of persons with MS 
reporting walking and mobility impairments5,6 and these impairments grow in severity with 
increases in disability status7,8. Rehabilitation9 and exercise10–12 have been proposed as possible 
therapies for walking dysfunction in persons with MS.  
Participation in regular physical activity and exercise, in particular, exert many benefits 
across healthy and diseased populations, including MS. Various aspects of the disease 
pathogenesis are positively impacted by exercise training13. For example, reliable and extensive 
evidence suggests exercise training improves muscular strength, aerobic capacity, and 
ambulatory performance14,15. The evidence also indicates improvements in fatigue, gait, balance, 
and quality of life as potential benefits following exercise training in persons with MS14,15.  
One set of researchers completed a systematic review in order to understand the effects of 
exercise training on MS symptoms and to inform the development of clinically appropriate 
physical activity guidelines for persons with MS16. This systematic review revealed consistent 
and strong evidence that aerobic capacity improved following two to three days per week of 
aerobic training for 30 to 60 minutes at moderate intensities16, which is particularly salient as 
 2 
decreased aerobic fitness and physiological deconditioning are associated with walking and gait 
impairments in MS11,17. Thus, the Canadian Physical Activity Guidelines (CPAG) for adults with 
MS recommend two-times per week of 30 minutes of moderate intensity aerobic activity and 
two-times per week of strength training for major muscle groups of the body18. These guidelines 
reflect a minimum dose for improving health-related physical fitness and are lower than the 
general population’s due to the typical physiological deconditioning and inactivity present in 
persons with MS18. Based on this systematic review for developing the CPAG, it is likely that 
meeting the guidelines would lead to improvements in aerobic capacity, mobility, and walking 
performance18. 
Persons with MS may experience greater benefits from participating in higher intensity 
exercise, such as high intensity interval training (HIIT), according to some researchers19–22. HIIT 
involves short periods of intense exercise that alternate with periods of recovery23. The work and 
rest intervals vary between studies, but typically are performed at a 1:1 work-to-rest ratio23. The 
intensity ranges from 80%-95% and 40%-50% of maximal heart rate for the work and rest 
intervals, respectively23. On a matched work basis, the physiological benefits reaped from HIIT 
are similar or even superior to traditional endurance exercise in healthy populations. These 
benefits include increased muscle oxidative capacity24, endurance performance25, reductions in 
subcutaneous and abdominal fat26, increased cardiovascular functioning27 and improved exercise 
adherence23. Some evidence suggests that HIIT training is superior to continuous, moderate 
exercise in terms of improving aerobic capacity, increasing ventilatory threshold, and enhancing 
gait economy in samples of healthy and people with heart disease28,29. 
Two comparisons between HIIT and continuous exercise training have been conducted in 
persons with MS. The first 12-week study identified significant improvements in walking 
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function (i.e., 2-minute walk performance), yet more dropouts and adverse events after the HIIT 
program were evident as compared to the continuous exercise program or a combination 
program of HIIT and continuous exercise22. The second study in persons with MS compared 
resistance training combined with HIIT or continuous aerobic training19. Significant 
improvements in peak power (+21±4%), time-to-exhaustion (+24±5%), and peak oxygen 
consumption (+17±5%) were evident in the HIIT group only and no adverse events or dropouts 
were reported19. Based on these two studies in MS, it appears that HIIT has the capacity to 
improve MS-relevant outcomes; however, the evidence regarding the feasibility and safety of 
these types of interventions is equivocal.  
The aforementioned studies used samples of persons with MS who generally did not have 
walking impairments. The benefits of engaging in HIIT in persons with MS with mobility 
impairments is relatively unknown. This type of inquiry is important because HIIT has the 
potential to improve cardiovascular fitness19 and walking performance22 in persons with MS with 
walking impairments, who are estimated to represent upwards of 75% of persons with MS5,6. 
Physiological deconditioning (i.e., decreases in aerobic capacity, balance, and muscular strength) 
may explain some of the variability in walking and gait impairments in persons with MS11,17. The 
next logical step is to identify the effects of HIIT on cardiovascular functioning, gait, and 
walking performance and to assess the efficacy and safety of this type of program in persons 
with MS with walking dysfunction.  
The American College of Sports Medicine (ACSM) recommends designing chronic 
exercise programs based upon the FITT-VP principal30,31. This mnemonic represents the 
frequency, intensity, type, time, volume, and progression of an exercise prescription. The HIIT 
paradigm can modify the intensity (i.e., how hard), time (i.e., duration or how long), volume (i.e., 
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amount), and progression (i.e., advancement) portions of a FITT-VP exercise prescription. 
Within HIIT, one can manipulate five major variables that correspond to the intensity, time, and 
volume principles: 1) work interval duration; 2) work interval intensity; 3) recovery interval 
duration; 4) recovery interval intensity; and 5) total work duration (i.e., interval number 
multiplied by interval duration). The ultimate goal for the current line of inquiry is to create a 
HIIT exercise prescription that is evidence-based and founded in the FITT-VP principals for 
persons with MS with walking impairments. As such, it is paramount to first ensure that the 
proposed prescription is safe and effective at acutely taxing the physiological systems 
responsible for the desired outcome.  
Chronic exercise adaptations are reflective of repeated exposures to properly curated 
acute exercise sessions that yield appropriate acute physiological (i.e., metabolic response, 
cardiopulmonary response, thermogenic response) and functional (i.e., walking performance and 
spatiotemporal parameters of gait) responses. The metabolic response governs the source of 
energy production for skeletal muscle contraction32. The cardiorespiratory system responds by 
increasing oxygen extraction, carbon dioxide production, cardiac output, ventilation, and 
pulmonary blood flow. Thermogenically, core temperatures can rise up to ~1 °C every 5-7 
minutes because of the body’s energy metabolism33. Some of these responses may be blunted or 
impaired in persons with MS, making them more important to monitor. Walking speed and gait 
parameters are the functional responses to acute exercise that could accrue to chronic 
improvements in mobility impairments following repeated exposures. Meta-analytic data have 
revealed significant, positive effects of exercise training on walking speed, walking endurance, 
spatiotemporal gait outcomes, and the metabolic cost of walking in persons with MS34,35. Thus, 
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examining these acute responses is vital to the present study to ensure that the ideal chronic 
adaptation is produced.  
Indeed, within-session, acute exercise responses to HIIT have been monitored in research 
with a variety of healthy and diseased populations36, including MS. A recent study compared the 
physiological and perceptual responses in persons with MS and healthy controls to light (i.e., 
45% peak work) continuous cycling, moderate (i.e 60% peak work) continuous cycling, and 
HIIT with alternating 30s of high intensity cycling (i.e., 90% peak work) and 30s of recovery37. 
For the within-session data, there were no significant differences between groups for heart rate, 
temperature variability, breathing perceived exertion or leg perceived exertion. During the 
recovery phase post-exercise, persons with MS required significantly longer to recover in terms 
of heart rate following the light session, core temperature following the moderate and HIIT 
sessions, breathing perceived exertion and leg perceived exertion following all exercise sessions. 
The gap in the literature that still remains is whether these data can be extrapolated to persons 
with MS who have walking impairments who are generally more physiologically deconditioned 
and may not be able to achieve such high intensities via cycling.  
The NIH’s mission to reduce burdens of disability is directly connected to the present 
research utilizing exercise to induce physical and functional improvements in persons with MS 
with mobility impairments38. The use of acute (i.e., single session) exercise research designs are 
crucial for designing exercise protocols pragmatically, safely, efficiently, and from a sound 
design perspective. Many exercise interventions are designed for persons without walking 
impairment and utilize treadmills or cycle ergometers, which may not be appropriate for those 
with moderate or severe impairment39. The ACSM has endorsed recumbent stepping as a suitable 
and practical assessment tool for evaluating cardiovascular fitness in neurological disorders40 and 
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a recent study has confirmed its efficacy for fitness assessment in MS66. Using recumbent 
stepping, which utilizes both arm and leg muscles to generate work, during a HIIT sessionmay 
be able to elicit a higher peak oxygen consumption that when repeated chronically could 
positively impact peak aerobic capacity and therefore walking performance in persons with 
mobility impairments.  
Overall, the present study aims to examine the feasibility and physiological and 
functional effects of a single session of HIIT aerobic exercise as compared to the CPAG protocol 
for aerobic activity performed on a recumbent stepper in persons with MS with mobility 
impairments. The proposed methodology would inform an evidence-based exercise prescription 
founded in FITT-VP principles that is appropriate for persons with MS with walking 
impairments. Results from this study will likely lead to larger randomized control trials (RCT) 
that will inform the exercise prescriptions developed for improving physiological and clinically 
relevant outcomes in persons with MS. This research is significant as it is the first to specifically 
examine the acute effects of high intensity interval aerobic exercise as compared to continuous 
aerobic exercise in MS with mobility impairments with the purpose of designing programs for 
improving physiological and functional outcomes that are clinically relevant. 
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The present review of the literature provides crucial information required for developing 
the study’s design and rationale for assessing the acute effects of high-intensity interval and 
continuous aerobic exercise on physiological and functional outcomes in persons with MS. The 
literature review will begin with a discussion on the epidemiology of MS. Next, the chapter will 
discuss the clinical course of the disease and the underlying pathophysiology of MS. The 
literature review will then focus on the relationship between exercise and MS. The chapter will 
then describe HIIT as an exercise paradigm with regards to its potential benefits in healthy and 
neurological populations. Next, the prevalence and importance of walking impairments and 
physiological deconditioning in persons with MS will be described. The significance of utilizing 
an acute research design of physiological and functional responses to exercise for determining 
the feasibility of HIIT in persons with MS with mobility impairment will then be discussed. The 
typical physiological and functional responses to exercise will then be explained in detail 
followed by any delineations that might be evident for persons with MS. Finally, the current 
literature identifying acute physiological and functional responses to HIIT in neurological 






MS is an immune-mediated neurodegenerative disease of the CNS that is initially marked 
by multi-focal areas of inflammation that lead to demyelination and consequent transection of 
axons1. It is estimated that there are 2.5 million people living with MS worldwide2. Within the 
United States, the prevalence of MS is one in one thousand 41 with more than 400,000 people 
affected3. The incidence rates of MS are estimated to be between 0.86 and 12.2 per 100,000 
person-years41. Based upon these data, MS is the most common non-traumatic disease affecting 
adults today2. The median age of diagnosis and survival rates are 37.2 and 30-43 years, 
respectively41,42. Because the disease is typically diagnosed between the ages of 20 and 50, MS 
disrupts the most productive years of life and is one of the most disabling diseases for young 
adults3. Women are reported to be three times more susceptible to the disease43. However, men 
who are diagnosed with MS tend to have a more progressive disease course3.  
Genetic and environmental risk factors have been proposed as possible causes of the 
disease3. The prevalence of MS is 1% for the general population3. However, when related to 
someone diagnosed with MS, the risk increases to 2-4%, indicating a genetic component to the 
disease3. Further, MS has a 30-40% concordance rate in monozygotic twins3. The prevalence of 
MS is higher in persons of European ancestry as compared to those of African, Hispanic, or 
Asian descent3,41,44, and is almost absent in persons of Native American or Eskimo descent3. 
African Americans tend to present with a more progressive course of the disease3. Around the 
world, the highest prevalence estimates are located in temperate climates in areas further away 
from the equator45,46, with increasing frequency in locations above 40q latitude3. Indeed, the 
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prevalence of MS is higher in the northern United States as compared to the southern United 
States42,44.  
 
CLINICAL COURSE OF MULTIPLE SCLEROSIS AND UNDERLYING 
PATHOPHYSIOLOGY 
 
There are four main subtypes of MS: relapsing-remitting multiple sclerosis (RRMS), 
secondary progressive multiple sclerosis (SPMS), primary progressive multiple sclerosis 
(PPMS), and progressive relapsing multiple sclerosis (PRMS)3. RRMS is diagnosed initially for 
between 85-90% of individuals with MS3. This disease course is characterized by periods of 
relapse, followed by remission, which can last from months to years3. Deficits experienced from 
relapse may either resolve entirely or prevail into remission3. Approximately 65% of persons 
with RRMS will progress to SPMS wherein acute attacks and exacerbations are separated by 
progressive neurological decline without definite periods of remission3. PPMS is diagnosed for 
approximately 10-15% of persons with MS who do not experience any remission following their 
initial MS symptoms3. These persons with MS experience an exclusively progressive and 
treacherously changing course of disability from the inception3. PRMS is the least common form 
of MS and describes a clinical course wherein a steady neurologic decline is later combined with 
clear, superimposed exacerbations3.  
The hallmark of MS is inflammation, which is followed by demyelination, gliotic 
sclerosis (a form of tissue scarring), axonal transection, and neurodegeneration3. These processes 
result in the clinical signs and symptoms of MS via the disruptions in neural signal patterns or an 
interruption in neural conduction3. The disease of MS occurs when the immune system attacks 
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itself, resulting in both acute and chronic inflammation3. These self-imposed attacks may be due 
to a failure to differentiate between foreign and domestic cells or exposure to an infectious agent 
thus leading to autoimmune demyelination3. The demyelination of brain and spinal cord neurons 
leads to disruptions in axonal conduction and possibly axonal loss3. Once damage occurs to 
axonal conduction, astrocytes and glial cells proliferate to produce glial scars, which act to 
isolate cellular damage3. Unfortunately, axonal loss or transection is irreversible and leads to the 
many permanent disabilities common for persons with MS3. Thus, persons with MS clinically 
present with decreases in whole-brain and spinal cord white matter and the formation of plaques 
or lesions3.   
The clinical manifestations of MS include optic neuritis, motor symptoms (i.e., heaviness, 
stiffness, weakness, pain or paralysis), sensory symptoms (i.e., tingling, burning, a pins-and-
needles sensation, or complete loss of sensation), and neuropsychiatric abnormalities (i.e., 
declines in language skills, memory, and intellectual function)4. The Expanded Disability Status 
Scale (EDSS) is used as the gold standard for quantifying disability status in MS47. The scale 
quantifies disability status into the following eight functional systems: 1 visual/optic, 2 
brainstem, 3 pyramidal, 4 cerebellar, 5 sensory, 6 bowel/bladder, 7 cerebral, and 8 ambulation. 
The EDSS is quantified into steps ranging from 0.0 (normal neurological exam) to 10.0 
(bedridden). Persons with MS who score between 1.0 and 3.5 are considered fully ambulatory. 
Those who score between 4.0 and 9.5 are considered to have ambulatory impairment47. 
Disease progression can worsen the symptoms of MS and may lead to walking and 
balance dysfunction, fatigue, pain, and depression48. Further, MS-related symptoms are 
associated with a reduced quality of life49–51. Walking dysfunction, in particular, is common in 
persons with MS as 75% report mobility and walking problems5,6 and often presents itself early 
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in the disease process6. With increasing disability, walking dysfunction also increases in persons 
with MS7,8. Because of the high occurrence of walking dysfunction and the heterogeneous 
experience of the disease, there is increasing interest in methods for restoring walking function, 
such as through rehabilitation9 and exercise10–12.  
 
EXERCISE AND MULTIPLE SCLEROSIS 
 
Definitions 
 Before detailing the impact of exercise on the symptoms experienced by persons with 
MS, it is important to first define the terms “physical activity,” “exercise,” and “physical 
fitness.”  According to the American College of Sports Medicine (ACSM), physical activity 
(PA) is defined as, “any bodily movement produced by the contraction of skeletal muscles that 
results in a substantial increase in caloric requirements over resting expenditure”30. Exercise is a 
subtype of PA that consists of “planned, structured, and repetitive bodily movement done to 
improve and/or maintain one or more components of physical fitness”30. Exercise intensity can 
be quantified utilizing heart rate (HR), oxygen consumption (V̇O2), or metabolic equivalents 
(METs). One MET is equivalent to 3.5 ml O2 per kg per minute. Often, exercise is prescribed by 
a physician or exercise specialist with the aim of improved fitness or health52. Physical fitness is 
a characteristic of a person’s ability to perform PA and is typically subdivided into health-related 
physical fitness and skill-related physical fitness. Health-related fitness includes 
cardiorespiratory endurance, body composition, muscular strength, muscular endurance, and 
flexibility. Skill-related physical fitness includes agility, coordination, balance, power, reaction 
time, and speed30.  
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Benefits of Exercise 
Persons with MS benefit from exercise in various aspects of their disease pathogenesis13. 
In a Nature Reviews article, researchers reviewed the literature regarding exercise training in MS 
within the context of the International Classification of Functioning, Disability, and Health 
model, which standardizes the pathogenesis and resulting consequences of health and 
disability14. The researchers identified consistent and widespread, positive effects on muscular 
strength, aerobic capacity and ambulatory performance following exercise training14. The 
literature was less prodigious, but suggested a possible benefit of exercise for improving fatigue, 
gait, balance, and quality of life in persons with MS14. Reliable evidence is lacking for the 
benefits of exercise on inflammation, neurodegeneration, axonal and neuronal loss, depression, 
cognition, activities of daily living, and recreation, leisure, and work14.  
Another topical review of the literature identified small, but important improvements in 
walking, fatigue, and depression for persons with MS after engaging in exercise training15. 
Improvements in walking performance, measured as walking speed and endurance, were larger 
following supervised exercise, which seemingly increased compliance rates15. Fatigue decreases 
of ~1/2 SD following exercise training were reported and subsequently categorized as a clinically 
meaningful difference in persons with MS15. The researchers identified two meta-analyses that 
reported between ~1/3 and ~1/2 SD improvements in depressive symptoms for persons with 
MS15.  Further, newer evidence suggests small, but potentially impactful benefits for balance and 
cognition following exercise training15. The researchers suggested improvements in balance may 
be due to microstructural changes in brain regions associated with postural control and balance15. 
Further, cognition, including improvements in verbal and non-verbal memory, may improve 
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through exercise training via neuroplasticity15. Collectively, these reviews suggest that exercise 
training benefits the various aspects of disability experienced by persons with MS.  
 
Canadian Physical Activity Guidelines for Adults with Multiple Sclerosis 
Physical activity and exercise have been proposed as possible methods for counteracting 
the symptoms of MS. The decrements in walking mobility may be related to physiological 
deconditioning17. Thus, it is important to identify any fitness improvements following exercise 
interventions in persons with MS16. Before the creation of the Canadian Physical Activity 
Guidelines (CPAG), a systematic review was completed in order to understand the effects of 
exercise training on fitness, mobility, fatigue, and health-related quality of life in persons with 
MS16. With regards to fitness, studies utilizing physical capacity outcomes (i.e., aerobic capacity, 
aerobic threshold, and power output) were included in the review. Nine aerobic exercise training 
studies that were minimally 2-3 days per week for 30 to 60 minutes at moderate intensities (i.e., 
60%-80% maximum work rate or 60% VO2max) reported significant improvements in aerobic 
capacity. Significant improvements in power output following aerobic exercise training on 2 or 
more days per week for 20 to 50 minutes at moderate intensity (i.e., 60% VO2max or at the 
anaerobic threshold) were supported by data from 5 separate studies. These data ultimately 
informed the generation of the aerobic component of the CPAG as there was consistent and 
strong evidence that aerobic training resulted in rises in aerobic capacity16. 
The CPAG for adults with MS recommend moderate intensity aerobic activity and 
strength training for major muscle groups for 30 minutes at a frequency of two-times per week18. 
These guidelines are lower than the general population’s due to the characteristic deconditioning 
and inactivity present in persons with MS and reflect a minimum dose for increasing health-
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related physical fitness18. It is likely that meeting the guidelines would lead to advances in 
mobility, improvements in quality of life, and reductions in fatigue levels18. 
 
HIGH INTENSITY INTERVAL TRAINING AS AN EXERCISE PARADIGM 
 
Several authors have indicated that engaging in higher intensity exercise may provide 
superior benefits to persons with MS19–22. According to the ACSM, high-intensity interval 
training (HIIT) is defined as “alternating short periods of intense exercise with recovery periods 
of passive or mild-intensity movement”23. The work intervals can range from 5 seconds to 3 
minutes, while the rest intervals are typically performed at a 1:1 ratio to the work or may last 
slightly longer. With regards to intensity based on maximal heart rate, the work interval ranges 
from 80%-95% of max heart rate, whereas the rest interval ranges from 40%-50% of max heart 
rate. The work/rest intervals are typically performed for 6 to 10 rounds, causing the total exercise 
bout to last between 10 to 40 minutes, depending on the prescribed interval times23.  
HIIT induces physiological benefits that are similar or even superior to traditional aerobic 
exercise on a matched-work basis29. Traditional Wingate tests represent a heavily studied HIIT 
paradigm where participants perform four to six all-out, 30s bouts of cycling with ~4 minutes of 
recovery29. This type of HIIT is extremely demanding physiologically, making it unsafe and 
intolerable for some and unappealing to others29. A newer, more practical model of HIIT has 
been extensively studied in the literature29. This model consists of 10 sets of 60s of work at 
~90% of maximal heart rate followed by 60s of recovery, resulting in 10 minutes of total work 
spread out over 20 minutes29. 
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HIIT in the General Population 
The ACSM recognizes the physiological benefits accrued from participating in HIIT to 
include: 1) increased aerobic and anaerobic fitness, 2) improved insulin sensitivity, glucose 
tolerance, and lipid profiles, 3) reduced arterial stiffness and improved blood pressure, 4) 
increased skeletal muscle fat oxidation and increased postexercise metabolism, 5) enhanced 
weight loss, 6) reduced abdominal and subcutaneous fat, and 7) increased exercise adherance23. 
In the general population, HIIT has yielded substantial improvements in endurance 
performance25, decreases in subcutaneous and abdominal fat26, and improved cardiovascular 
functioning27. Quick muscle remodeling towards a more oxidative phenotype and improvements 
in oxidative performance are reported following HIIT29. Further, data from RCTs have identified 
HIIT as a superior exercise modality to moderate-intensity continuous exercise for increasing 
aerobic capacity, ventilatory threshold, gait economy, and endothelial functioning in healthy 
adults and persons with heart disease28,29.   
 A recent systematic review and meta-analysis identified the effectiveness of high-
intensity interval and endurance training for improving aerobic capacity53. The meta-analysis 
included 28 (n=728), randomized controlled trials comparing HIIT to continuous exercise for 
improving maximal oxygen uptake (VO2max) in healthy adults aged 18-45. The data revealed 
significantly larger increases in maximal oxygen uptake following both endurance training and 
HIIT as compared to no exercise. The improvements in aerobic capacity are magnified following 
both modes of aerobic exercise if the aerobic capacity of the study population is lower at 
baseline. Based on these data, HIIT provides equivalent benefits to maximal oxygen uptake than 
traditional endurance training in healthy, young to middle-aged adults53.  
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Collectively, these data suggest that HIIT is equivalent and perhaps superior to traditional 
endurance training in producing physiological and functional benefits. This is encouraging as 
many persons with MS are physiologically deconditioned17 and these data indicate a potentially 
superior benefit of HIIT for persons with MS, whose disease severity is associated with 
cardiopulmonary fitness54. 
 
HIIT in Neurological Populations 
 The potential benefits of HIIT have been examined in neurological populations, like 
stroke and multiple sclerosis. Stroke is a neurological condition that is the result of either 
vascular ischemia (i.e., restriction of blood supply to tissues) or intracerebral hemorrhage (i.e., 
blood vessel bursts in the brain causing blood leakage)30. Similar to MS, the consequences of 
having a stroke include decreases in functional capacity and higher energy expenditures to 
perform routine activities30,55. Evidence-based interventions and exercise guidelines for persons 
after stroke include moderate-intensity continuous aerobic exercise aimed at improving 
functional activity limitations36, aerobic deconditioning and cardiovascular health, further 
mirroring the guidelines for persons with MS18.  
Two RCTs have assessed the efficacy of treadmill HIIT training during inpatient 
rehabilitation for persons with stroke56,57. One study identified significantly greater 
improvements in gait speed (mean 0.15 m/s)  and stride length (mean 0.16 m) for sub-acute 
stroke patients performing 10 sessions of short interval walking trials as compared to steady 
speed walking trials56. Another study compared three, 4-week gait therapies (structured speed-
dependent treadmill training (i.e., HIIT), limited progressive treadmill training, and conventional 
gait training) on clinical outcomes (i.e., walking speed, cadence, stride length, and Functional 
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Ambulation Category scores) in sixty ambulatory poststroke patients. The data identified 
significant improvements in gait speed, cadence, stride length, and functional ambulation for the 
structure speed-dependent treadmill training as compared to the other form of treadmill training 
and conventional gait therapy57. Two more recent single-group, pre-post-test designed trials in 
subacute and chronic stroke have identified significant increases in the Timed Up and Go, gait 
speed, endurance, and economy, and aerobic capacity following 4 to 6 weeks of treadmill HIIT 
training58,59.  
Based on the popularity and benefits yielded from HIIT in other clinical populations29, 
researchers have begun applying this exercise paradigm in persons with MS. To date, two 
research studies have conducted exercise training interventions utilizing a HIIT paradigm in 
persons with MS19,22. The first study compared three aerobic exercise prescriptions (i.e., 
continuous at 45% peak power, intermittent with 30s of work at 90% peak power and 30s of rest, 
and a combined protocol with 50% of time performing the intermittent prescription and 50% of 
time performing the continuous prescription) in persons with MS22. Fifty-five persons 
participated in the study and they were randomly assigned to one of the three groups. The 
exercise training occurred two times per week for 20 minutes and participants were assessed at 
baseline, at 6 weeks, at 12 weeks, and at 12 weeks after the termination of the training for 
follow-up. The primary outcome measure was walking endurance measured with the 2-minute 
walk. No differences were found between groups (p>.05). The intermittent group increased their 
2-minute walk distance by 12.94±4.71m (partial eta2=.28) after 6 weeks and this was maintained 
for the remainder of the study. More dropouts and adverse events (e.g. leg pain during cycling) 
occurred in the intermittent and combined groups. Thus, the authors concluded that intermittent 
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exercise may provide superior benefits to walking function in persons with MS, but it may be 
less tolerated22.  
The second study conducted in a MS population included a 12-week study comparing 
HIIT to continuous aerobic training, both in combination with resistance training19. Both exercise 
training conditions were compared to a sedentary, control group. A total of 34 persons with MS 
with mild disability (EDSS range 2.0-3.0) participated in the study and were randomly assigned 
to one of the three groups. The HIIT training program progressed from 5 sets of 1-minute 
interspersed by 1-minute rest intervals to 5 sets of 2-minute intervals interspersed with 1-minute 
rest intervals on a cycle ergometer. For the first and second 6 weeks of the intervention, the 
intensity was set at 100% and 100%-120% of the maximal workload heart rate, respectively. The 
continuous aerobic training progressed from 1, 6-minute session to 2, 10-minute sessions at 80-
90% of maximal heart rate on a cycle ergometer or treadmill. Each aerobic session was followed 
by a moderate-to-high intensity, full body resistance session. Participants were expected to attend 
sessions 5 times every two weeks19.  
Following the intervention, participants in the HIIT group achieved significant 
improvements in peak power (+21±4%), time-to-exhaustion (+24±5%), and peak oxygen 
consumption (+17±5%)19. No significant changes occurred for the sedentary or continuous 
aerobic training group. The HIIT group further saw improvements in Type II (+23±7%) and 
Type IIa (+23±6%) fiber type cross sectional area, whereas the continuous group achieved 
significant increases in Type I (+29±6%) fiber types. Lean tissue mass (+1.4±0.5%) increased 
overall for the HIIT group only. Body fat percentage decreased for both the HIIT (-3.9±2.0%) 
and continuous groups HIIT (-2.5±1.2%), respectively. Isometric knee flexion strength (p>.05) 
improved only in the HIIT group. Physical activity levels, measured with the Physical Activity 
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Scale for Individuals with Disabilities, significantly increased for the HIIT (+86±27%) and 
continuous groups (+73±19%), but not for the sedentary group.  Importantly, no dropouts or 
adverse events occurred during the duration of the intervention and the researchers report the 
training as being safe and well tolerated19.  
However, there are serious methodological limitations to the aforementioned study19. The 
exercise interventions utilized a combination of aerobic and resistance exercise. This makes it 
difficult to discern if any muscular adaptations are due purely to the HIIT or due to the resistance 
training or both. Further, the continuous aerobic exercise is at a moderate-to-high intensity and 
initially only lasts for 6 minutes. The exercise duration increases to 20 minutes by the end of the 
intervention, but it is unclear when this transition occurs. The authors do not clearly state 
whether this exercise prescription meets any current guidelines for exercise training, like the 
CPAG for persons with MS18. Moreover, the study participants exhibited mild disability without 
any walking impairments. The results of this study cannot be extrapolated to persons with 
mobility impairments19.  
 
WALKING DYSFUNCTION & PHYSIOLOGICAL DECONDITIONING IN MS 
 
The current literature regarding HIIT in MS has primarily utilized participant samples 
without mobility impairments, making its effects and potential benefits for persons who 
experience walking dysfunction relatively unknown. Thus, the present study aims to examine if 
the HIIT exercise paradigm can be safely and effectively applied to persons with MS who have 
walking and mobility impairments. This inquiry is important because an alarmingly high 
percentage of persons with MS exhibit impairments in mobility and walking function (i.e., 
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75%)5,6. Persons with MS describe walking and gait as one of the most valuable bodily 
functions60. In a survey-based study identifying the impact of walking impairment, 70% of 
participants who had walking dysfunction described their impairment as one of the most 
challenging aspects of their disease61.  
Other studies have identified impairments in persons with MS as compared to healthy 
controls in walking speed and spatiotemporal properties of gait62,63. For example, persons with 
MS exhibited significant decrements in walking speed measured as 0.7 seconds slower during 
the Timed 25 Foot Walk Test (T25FW)62. When broken down by clinical disability, the speed 
decrements significantly increased with increasing disability status62. In relation to gait, 
ambulatory persons with MS with mild disability (i.e., did not use an assistive device) 
demonstrated significant decreases in velocity (i.e., walked slower), cadence (i.e., fewer steps), 
and step length (i.e., shorter steps) as compared to healthy controls63. Further, significantly 
higher bases of support (i.e., wider steps) and percent of gait cycle in double support (i.e., two 
feet on the ground) were reported for persons with MS63. Thus, a range of persons with MS 
experience walking impairment and this may or may not occur when an assistive device is used. 
According to some scientists, physiological deconditioning may contribute to these 
walking and gait deficits in MS11,17. Physiological deconditioning refers to reductions in aerobic 
capacity, balance and muscular strength17. Physiological deconditioning is prevalent in persons 
with MS17,64,65 and may be a result of the high amount of physical inactivity66 and sedentary 
behavior67 reported in this population. Further, the metabolic efficiency (i.e., energy cost) of 
walking is correlated with self-reported walking impairment and spatiotemporal gait outcomes in 
persons with MS68.  
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One study in particular aimed to identify any links between physiological deconditioning 
and walking and gait impairments in persons with MS17. The researchers matched 31 persons 
with MS to 31 healthy controls and assessed their peak aerobic capacity (VO2), lower limb 
asymmetry, balance, walking speed, and spatiotemporal parameters of gait17. Of note, significant 
differences were reported between persons with MS and healthy controls for aerobic capacity 
(d=-0.72), walking speed (via T25FW, d=0.67), gait velocity (d=-.66), step length (d=-.73), base 
of support (d=0.44), and percent spent in double support (d=0.48). The reported effect sizes 
indicate that persons with MS have moderately reduced aerobic capacities and have moderate to 
large decrements in walking and gait metrics (i.e., take longer to walk 25 feet, take shorter steps, 
have slower velocities, take wider steps, and spend more time in double support) as compared to 
controls17.  
In their regression analyses, the researchers reported that aerobic capacity accounted for 
differences between persons with MS and controls in gait velocity (∆R2=.270) and time spent in 
double support (∆R2=.339) 17. Aerobic capacity and lower limb asymmetry together accounted 
for differences in T25FW (∆R2=.283) and step length (∆R2=.300). Within the MS subsample, 
peak aerobic capacity was significantly associated with T25FW times and all gait metrics. In the 
regression analyses of the MS subsample, aerobic capacity explained significant variance in 
double support (∆R2=.318), while aerobic capacity coupled with lower limb asymmetry 
explained variance in gait velocity (∆R2=.322) and step length (.318). Together, these results 
would indicate that variability in walking and gait impairments in persons with MS may be 
explained by physiological deconditioning17.  
As mentioned previously, 12-weeks of a HIIT intervention in ambulatory persons with 
MS can lead to significant improvements in walking performance (i.e., two-minute walk)22 and 
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aerobic capacity (i.e., peak oxygen consumption, peak power, and time to exhaustion)19. It is also 
apparent that physiological deconditioning is associated with mobility impairments in persons 
with MS11,17. The logical next step is to apply HIIT in persons with MS who exhibit walking and 
gait impairments. Before initiating a full-scale HIIT intervention, however, it is important to first 
understand the physiological and functional responses of persons with MS to exercise and HIIT, 
in particular. Such an analysis at an acute level will ensure the HIIT prescription designed for 
improving physiological conditioning (i.e., cardiorespiratory fitness) and walking impairment is 
taxing the body appropriately. 
 
PHYSIOLOGICAL AND FUNCTIONAL RESPONSES TO EXERCISE IN PERSONS 
WITH MULTIPLE SCLEROSIS 
 
The ACSM’s Guide to Exercise Testing and Prescription suggests creating chronic 
exercise programs based upon the FITT-VP principal30,31. The FITT-VP principal is a mnemonic 
to represent Frequency, Intensity, Time, Type, Volume, and Progression. Frequency refers to 
how many times per week an exercise session is performed. Intensity can be defined relatively as 
a percentage of a best performance outcome (e.g., heart rate reserve, maximal heart rate, or 
maximal oxygen consumption) or absolutely in metabolic equivalents and thus identifies how 
hard a person is training. Time represents the duration or how long the person is engaged in the 
exercise session and exercise modality, such as treadmill running or recumbent stepping, are 
referred to as Type. Volume is the total amount of work performed and Progression indicates the 
advancement of the chronic exercise program30. Some researchers propose that many exercise 
interventions have not been optimized to consider improvements in fitness as a targeted 
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outcome17 and others have called for more rigorous research in terms of identifying the ideal 
exercise prescription through better designs of RCTs16. Thus, utilizing the FITT-VP principal is 
ideal for addressing these concerns and optimizing a HITT prescription for persons with MS with 
mobility impairments.   
Modifying each component of the FITT-VP principal can lead to vastly different results. 
HIIT, in particular, will modify the Intensity portion of the FITT-VP principal in relation to the 
CPAG for adults with MS18. Because the main outcome of a HIIT intervention is ultimately to 
improve cardiorespiratory fitness and consequently walking performance11,17, it is important to 
first identify how one session of HIIT affects energy metabolism and thermogenic and 
cardiorespiratory responses as these are critical components to aerobic capacity32. Further, it is 
important to monitor perceived exertion and mood responses to HIIT exercise to identify any 
negative aspects of the session that may preclude participants from wanting to engage in the 
exercise chronically. If the acute HIIT protocol is safe and effective, it can be assumed that 
repeated, acute participation will lead to chronic adaptations. Thus, the subsequent literature will 
first describe the bioenergetic and metabolic response, cardiorespiratory response, thermogenic 
response, and functional response to acute exercise in the general population and any variation 
observed in persons with MS. This will be followed by a discussion of these physiological and 
functional responses specific to HIIT sessions in neurological populations. 
 
Bioenergetic & Metabolic Responses 
 Upon the initiation of exercise, energy is required in the form of adenosine triphosphate 
(ATP) in order to support muscle contraction32. The energy is supplied through either substrate 
level phosphorylation (i.e., anaerobic hydrolysis of creatine phosphate and anaerobic oxidation 
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of glucose) or oxidative phosphorylation (aerobic oxidation of substrates glycogen and fatty 
acids)33. Substrate level phosphorylation does not utilize oxygen to convert adenosine 
diphosphate (ADP) into ATP and occurs outside of the mitochondrion within the sarcoplasm of 
the muscle cell. The anaerobic hydrolysis of creatine phosphate (i.e., the phosphagen system) 
and anaerobic oxidation of glucose (i.e., glycolysis) produce small quantities of ATP at a fast 
rate. Oxidative phosphorylation utilizes oxygen to phosphorylase ADP into ATP inside of the 
mitochondrion in the muscle cell. The citric acid cycle and electron transport chain (ETC) 
produce a substantial amount of ATP at a slower rate. During exercise, one energy system will 
dominate, however, all will contribute. As exercise duration increases, there is a shift from 
anaerobic to aerobic sources of energy33.  
At the onset of exercise, local stores of PCr are hydrolyzed by creatine kinase to produce 
Cr and inorganic phosphate (Pi)32. The three main phosphagens include ATP, ADP, and creatine 
phosphate (PCr) 33. The availability of PCr stored in the muscle cell allows for the immediate 
resynthesis of ATP. The enzyme creatine kinase cleaves the phosphate bond off of the PCr 
molecule to yield an Pi, which provides the energy for muscle contraction. PCr is the limiting 
factor of the phosphagen system. The first few seconds (i.e., 3-15s) during intense muscular 
effort utilize this system to prevent energy depletion by forming more ATP33. This bioenergetic 
mechanism accounts for the O2 deficit in the first few minutes of exercise and the recovery 
payment of the O2 debt32.  
Glycolysis and glycogenolysis are the processes of breaking down glucose or glycogen 
into pyruvate, respectively33. Both processes are fast-acting and produce two net ATPs. Further, 
coenzyme nicotinamide adenine dinucleotide (NAD+) accepts two electrons which can be carried 
into the mitochondrion to be utilized in the ETC. Each molecule of glucose used during 
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glycolysis yields two molecules of pyruvate. Pyruvate can either be converted into lactic acid or 
acetyl coenzyme A(CoA), depending on the availability of oxygen33. If oxygen is not available, 
pyruvate can serve as the final electron acceptor from the NADH when the muscle cell becomes 
oxygen poor, thus forming lactate32. If oxygen is available, pyruvate is committed to the 
mitochondria via pyruvate dehydrogenase and enters the citric acid cycle33.   
If sufficient oxygen is available to the muscle cell during glycolysis, acetyl CoA, 
produced by the further breakdown of pyruvate or the beta oxidation of fatty acids33. During the 
citric acid cycle, Acetyl CoA combines with oxaloacetate to form citrate, which then undergoes a 
series of reactions to regenerate oxaloacetate and produces two molecules of carbon dioxide 
(CO2). NAD+ and flavin adenine dinucleotide (FAD2+) accept electrons in form of H+ ions and 
shuttle these electrons into the ETC to produce a substantial amount of ATP for the muscle cell. 
Once NADH and FADH2 enter the ETC, the electrons are removed from the H+ ions and are 
shuttled down a cytochrome pathway where enough energy is released to rephosphorylate ADP 
into ATP.  Oxygen accepts the electrons that are passed along cytochromes and combines with 
H+ to form water. During exercise, the cardiorespiratory system must provide adequate amounts 
of oxygen in order to aerobically regenerate the ATP required for muscle contraction32. Five-
sixths and one-sixth of the energy required during exercise is supplied from CHO and FAT, 
respectively32.  
 The different metabolic mechanisms discussed here have varying effects on gas 
exchange32. When the phosphagen system is used to split PCr (a relatively acidic compound), the 
cellular environment becomes less acidic because Cr is neutral in water. Thus, the CO2 produced 
during the citric acid cycle is converted into bicarbonate (HCO3-) in the tissues. This decreases 
the CO2 output at the airway relative to O2 uptake, which creates the early kinetic disparity 
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between V̇CO2 relative to V̇O2. The use of the glycolytic energy system to produce ATP 
anaerobically by converting pyruvate into lactate causes H+ to be produced and subsequently 
buffered predominantly by HCO3-. By buffering the H+ ions, molecules of water (H2O) and CO2 
are produced. During oxidative phosphorylation within the muscle cell, O2 is consumed and CO2 
is produced in proportion to the ratio of carbohydrate to fatty acid in the substrate being oxidized 
for ATP regeneration. Thus, the latter two mechanisms produce enough CO2 to increase V̇CO2 
relative to V̇O232.  
 A recent review article has identified the muscular and metabolic dysfunctions evident in 
persons with MS69. Persons with MS exhibit slowed exercise-onset oxygen uptake (VO2) 
kinetics, which may be attributed to lower blood flow to the working muscles. Lowered force 
generation, fiber atrophy, and enzymatic disturbances as compared to healthy controls have also 
been reported. Further, metabolic impairments that included fat oxidation, lipolysis, and glucose 
tolerance were reported for persons with MS. Indeed, one study included in the review identified 
the relationship between metabolic flexibility (i.e., the ability to adjust fuel oxidation to fuel 
availability) and exercise intolerance in persons with MS70. The researchers compared 
carbohydrate and lipid oxidation in 16 persons with MS to 16 matched healthy controls while 
fasted, postprandial, and during 40-minutes of moderate-intensity exercise. Carbohydrate 
oxidation was increased, while lipid oxidation was decreased for persons with MS as compared 
to healthy controls during fasting and postprandial phases. During the exercise bout, 
carbohydrate oxidation increased sharply in the first 20 minutes, subsequently decreased in the 
remaining 20 minutes, and never reached a steady state. The authors contributed this 
dysregulation to an inferior autonomic response to exercise that resulted in a blunted response of 
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fat mobilization as evidenced by a higher respiratory exchange ratio during the acute exercise 
bout70. 
 
Cardiorespiratory & Pulmonary Responses 
 During physical exercise, the contracting muscles lead to increases in respiratory 
demands (i.e., O2 consumption and CO2 production) that are met through an interaction between 
the physiological control mechanisms of the cardiorespiratory and ventilatory systems32. Muscle 
contraction requires ATP, which can be metabolically produced aerobically or anaerobically. 
During exercise, oxygen is needed to meet the energy demands of the muscle. Physiologically, 
the muscles extract more O2 from the blood perfusing the muscles, heart rate and stroke volume 
increase, leading to an increase in cardiac output, pulmonary blood flow by recruitment and 
vasodilation of pulmonary blood vessels increase, and ventilation (i.e., tidal volume multiplied 
by breathing rate) increases. Collectively, these processes support the large increase in O2 
utilization by the muscles (Q̇O2). The pulmonary blood flow and degree of O2 desaturation of 
hemoglobin in the pulmonary capillary blood proportionately determine the rate that oxygen is 
extracted from the alveoli (V̇O2).  Ventilation increases in order to achieve arterial CO2 and 
hydrogen ion homeostasis following the increase in CO2 production at the muscular level which 
is ultimately delivered to the lungs by venous return (Q̇CO2)32. 
 Varying intensities of exercise affect these physiological components differentially32. In 
general, the rise in cardiac output is comparatively small for the upsurge in metabolic rate, thus 
indicating an increased extraction of O2 from and CO2 loading into the blood by the muscles. 
During moderate intensity exercise, minute ventilation increases in approximate proportion to the 
new CO2 brought to the lungs via venous return. However, during high-intensity exercise, minute 
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ventilation increases to a greater extent to compensate for the metabolic acidosis that occurs 
when energy stores are reduced or depleted32.  
Cardiopulmonary exercise testing (CPET) is an ideal method for examining the effects of 
aerobic exercise in healthy populations32 and persons with MS71. CPET involves maximal, 
graded exercise which is paired with indirect spirometry in order to assess expired gases (e.g. O2 
and CO2) in response to a known exercise stress71. The gas exchange at the airway is the result of 
cardiac output, pulmonary blood flow, peripheral O2 extraction, and ventilation32. Thus, the 
adequacy of the cardiovascular transport of O2 is evident in the gas exchange measured via 
indirect spirometry. All organ systems essential for exercise are evaluated simultaneously 
through CPET32. CPET is symptom-limited in persons with MS, but is a comprehensive 
assessment of exercise tolerance and the responses of the cellular, pulmonary, skeletal, and 
cardiorespiratory systems32,71,72. The use of indirect spirometry during CPET allows the 
researcher to distinguish between normal and abnormal responses to exercise and is one of the 
most inexpensive was to examine the pathophysiology of the cardiovascular and ventilatory 
systems32.  
The outcomes of CPET include measures of oxygen uptake (VO2), oxygen uptake 
efficiency slopes (OUES), carbon dioxide production (VCO2), and ventilation (VE)71,73. Peak 
oxygen consumption is typically considered the gold-standard CPET measure; although OUES is 
an alternative marker of exercise tolerance that is not effort-limited (i.e., maximal effort is not 
necessary). Importantly, the different CPET outcomes can be graphically and mathematically 
calculated to represent the different physiological systems involved71. For instance, the 
VE/VCO2 slope represents ventilator efficiency and limitations71,72, while the VO2/Power slope 
reflects the capability of oxygen transport to working muscles32,71. Moreover, HRpeak and 
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VO2/HR provide information regarding cardiac capacity. Further, these outcome data have been 
established as clinically relevant in other diseased populations and have served as prognostic and 
cardiovascular risk indicators32,71,74–76. 
Cardiopulmonary fitness, or peak aerobic capacity measured as VO2peak, is associated 
with disease severity and neurological disability in persons with MS54,77, making it an important 
outcome measure for any exercise intervention. As compared to age- and sex-matched healthy 
adults, persons with MS have decreased cardiorespiratory functioning as evidenced by generally 
lower maximal aerobic capacity30. Maximal aerobic capacity decreases with increasing disability 
in persons with MS30,78,79. One recent study aimed to provide a comprehensive profile of CPET 
in ambulatory persons with MS71. This study compared 162 persons with MS to 80 healthy 
controls who underwent a validated CPET on a leg ergometer. Maximal oxygen uptake (VO2), 
carbon dioxide production (VCO2), ventilation (VE), respiratory exchange ratio (RER), work 
rate (W), and heart rate (HR) were measured throughout the CPET. Ventilatory anaerobic 
threshold (VO2/VCO2), VE/VCO2 slope, VO2/power slope, and OUES were calculated using 
standard guidelines. Persons with MS had significantly lower VO2peak (independent and relative 
to body weight), HRpeak, RERpeak, VO2/HR, and VEpeak than controls. Further, VO2peak decreased 
for persons with MS as disability level decreased. Interestingly, the absolute ventilatory 
threshold (VE) was significantly lower for persons with MS as compared to controls. These data 
suggest that persons with MS experience an earlier onset of fatigue and are unable to sustain an 
exercise workload for an extended time period. The VO2/power slope and peak power metrics 
were significantly lower for persons with MS as compared to controls. These data indicate 
persons with MS may have a metabolic inefficiency for converting metabolic energy into 
potential chemical energy and are unable to achieve as high of a workload, respectively. Finally, 
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the OUES was lower and less steep for persons with MS, suggesting that persons with MS have a 
lower efficiency of O2 uptake with increases in ventilation. Thus, persons with MS exhibit 
alterations in several cardiopulmonary outcomes during CPET71.  
A recent systematic review and meta-analysis identified significantly impaired aerobic 
capacity via VO2peak levels and these were further associated with factors on all levels of the 
International Classification of Functioning, Disability, and Health model80. However, exercise 
training studies indicate that 3- to 6-months of exercise training yielded improvements in 
V̇O2peak, functional capacity, lung function, and delayed onset of fatigue30,78,81. Some data even 
indicate that a 5-time per week exercise training program lasting 4-weeks in length has the 
capacity to increase the aerobic threshold in persons with MS82. Even though persons with MS 
exhibit lower levels of cardiopulmonary fitness, they are able to improve their functioning 
through exercise training.  
Persons with MS produce a blunted heart rate and blood pressure response to graded 
exercise tests as compared to healthy controls, even though their heart rate and blood pressure 
responses are commonly linear with respect to work rate30,79. Upwards of 50% of individuals 
with MS display orthostatic dizziness, which is marker of the altered regulation of blood 
pressure83. Further, autonomic impairments during standard cardiovascular functioning tests, 
such as the Valsalva maneuver, hand grip test, deep breathing, and standing test, are present in 
7% to 60% of persons with MS sampled84.   
Data comparing persons with MS to age-, sex-, height-, and weight-matched healthy 
controls indicated that persons with MS had significantly different arterial function, but not 
structure85. Forearm blood flow at baseline conditions and during a reactive hyperemia challenge 
subsequent to cuff occlusion was significantly lower and central pulse wave velocity was 
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significantly higher in persons with MS85. These subclinical markers of atherosclerosis were 
accounted for by the significantly lower physical activity levels reported by persons with MS85. 
Persons with MS further produce significantly lower muscle sympathetic nerve activity and 
plasma concentrations of norepinephrine86. These data suggest that the sympathetic outflow 
signal from the central nervous system to the cardiovascular system is attenuated in persons with 
MS86. Researchers suggest that the impaired control of skeletal muscle circulation may be due to 
dysregulation originating both centrally (i.e., sympathetic outflow) and peripherally (i.e., 
impaired responsiveness to mechano- and chemoreceptors within the muscle)84. With regards to 
cardiovascular functioning and dynamic exercise behavior, blunted elevations in heart rate and 
systolic blood pressure in persons with MS as compared to controls have been reported following 
graded arm ergometry84,87 and graded cycling84,88.    
 
Thermogenic Responses 
  The hypothalamus is responsible for the temperature regulation of the body33. The 
hypothalamus regulates the body’s core temperature to ~37 °C ± 1°C. Two mechanisms are 
utilized to activate the regulatory signals of the hypothalamus: thermal receptors on the periphery 
(i.e., skin) depolarize action potentials to the hypothalamus and blood temperature changes in the 
blood physically perfusing the hypothalamus. The maintenance and regulation of the body’s core 
temperature is a consequence of heat loss (via radiation, conduction, convection, and 
evaporation) and heat gain (via basal metabolic rate, muscular activity, hormones, thermic effect 
of food, postural changes, and environment). Core temperature rises when heat gain exceeds heat 
loss and core temperature decreases when the opposite occurs. During exercise, the metabolism 
of elite athletes can produce up to ~20.0 kcal/min which results in a ~1 °C increase in 
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temperature every 5-7 minutes. Heat loss occurs most importantly through evaporative cooling 
via sweating and respiratory passages. Maximal sweating can induce heat losses of ~18 
kcal/minute under maximal conditions. The circulatory system additionally supports core 
temperature homeostasis. Peripheral vessels will dilate as warmer blood flows to the periphery. 
Overall, the body will trigger a sweating rate upwards of 2.0 L/hr during exercise in attempts to 
maintain the thermal balance33.   
It is estimated that between 60-80% of persons with MS experience Uhthoff’s 
phenomenon: a transient worsening of clinical signs and neurological symptoms as a result of 
elevated body temperature following exposure to hot environments or even exercise84,89,90. The 
contemporary MS and thermoregulation evidence suggests that increased temperature alters 
conduction characteristics within the central nervous system and thermoeffector responses are 
impaired in persons with MS89. Due to the disease related bladder symptoms (i.e., retention, 
urgency, leakage), persons with MS may voluntarily restrict their fluid intake89. This behavior 
can lead to reductions in plasma volume, which consequently impact thermoregulatory 
mechanisms like sweating89. For example, persons with MS may have a reduced sweat function, 
resulting in greater heat storage and changes in core temperature as a given rate of heat 
production84. Rises in core temperature above a threshold of 0.5° can lead to reversible nerve 
conduction slowing or block in demyelinated axons91. Collectively, increases in core temp may 
lead to deleterious effects on walking for thermosensitive individuals with MS.  
Accordingly, many practitioners caution patients from the potentially deleterious effects 
of vigorous exercise. Following exercise training, classic thermoregulatory adaptations were 
absent in persons with MS, indicating impaired autonomic control of thermoregulatory effector 
responses84,92. One study has compared the thermoregulatory responses to 60 minutes of cycling 
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in persons with MS and matched, healthy controls and reported a two-fold increase in rectal 
temperature post-exercise for persons with MS84. Data from another study indicated significant 
associations between increases in core temperature and decrements in walking performance, 
measured as frequency of steps, and T25FW speed immediately following 30-minutes of 
moderately intensive exercise93. Increases in core temperature have further been linked to 
increases in perceived severity of symptoms94. Some researchers have suggested minimizing 
exercise intensity or utilizing cooling strategies to reduce the internal temperature burden on 
persons with MS84. Although precooling may help persons with MS tolerate these potentially 
negative symptoms of exercise-induced rises in core temperature93, exercise is still recommended 
for persons with MS and increases in temperature do not affect the acute effects of exercise on 
inhibitory control91.  
 
Functional Responses 
Walking is considered a safe, low-to-moderate intensity form of physical activity and 
exercise30. According to the ACSM’s Preparticipation Health Screening Recommendations30, 
individuals who are considered moderate risk with two or more cardiovascular risk factors may 
begin a light-to-moderate walking program without consulting their physician. A person’s gait 
describes the manner in which they walk (i.e., the spatiotemporal components of gait) and can be 
quantified as gait speed or velocity, cadence, step time, step length, base of support, and swing17. 
Several cross-sectional analyses revealed evidence supporting an association between 
physical activity levels and walking and mobility impairments in persons with MS11. Researchers 
have also utilized panel analyses to determine if physical activity levels are predictive of walking 
dysfunction over a 6-month period. In a sample of 269 persons with MS, the analyses indicated 
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that self-reported, baseline physical activity, measured using the Godin Leisure-Time Exercise 
Questionnaire and International Physical Activity Questionnaire, had a direct effect on self-
reported walking impairment, measured using the Multiple Sclerosis Walking Scale-12 and 
Patient Determined Disease Steps (path coefficient=-0.31)95. Further, self-reported, changes in 
physical activity during the 6-month period had direct effects on the self-reported changes in 
walking impairment (path coefficient =-0.16)95. These data provide preliminary evidence for the 
predictive value of physical activity levels for future walking impairment in persons with MS95 
and further supports the notion that exercise interventions aimed at increasing physical activity 
could have a substantial impact via reducing, maintaining, or even improving this disability in 
persons with MS11. 
One meta-analysis identified the effects of exercise training on walking and mobility in 
persons with MS10. The meta-analysis conducted an extensive literature review search and 
included exercise training studies that measured walking mobility with objective (e.g. T25FW, 
6MW, spatiotemporal gait outcomes, and O2 cost of walking) and subjective measures (e.g. 
MSWS-12) pre- and post-exercise training10. Twenty-two publications with 66 effect sizes were 
included in the final analyses10. The weighted mean effect size of exercise improving walking 
mobility was small (g=0.19), but may have clinical relevance when considering the effect sizes 
reported for disease modifying therapies (d=0.20) for decreasing disease progression and 
disability scores96. 
A more recent meta-analysis quantified improvements in walking performance following 
randomized controlled trials of exercise training in persons with MS35. Thirteen studies that 
utilized only objective walking outcome variables (i.e., 10-m walk test, T25FW, two-minute 
walk test, six-minute walk test, and timed up and go test) were included in the final analyses. 
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Walking speed significantly improved for the 10-m walk test (MD = -1.76s, p<.001), but not the 
T25FW (MD=-.59s, p=.55). Walking distance significantly increased for both the 6-minute walk 
test (MD=36.46, p<.001) and 2-minute walk test (MD=12.51, p=.001). According to the authors, 
the improvements in the 2-minute walk test and 10-m walk test were clinically meaningful 
differences at a 19% and 16.5% improvement. The included exercise interventions did not 
significantly improve timed up and go performance (p>.05). Collectively, these results indicate 
improvements in walking ability for persons with MS following exercise training.  
 An additional functional outcome to consider for persons with MS is cognition and 
information processing speed. Recent estimates have identified 40% to 65% as presenting with 
cognitive dysfunction due to their MS97. Deficits in cognitive functioning commonly arise in 
information processing speed, learning and memory, or executive function domains in persons 
with MS98. Due to the highly disabling nature of cognitive impairment for persons with MS, it 
has been associated with unemployment and loss of employment, social dysfunction, depression, 
loss of driving abilities, and reduced independence98. Currently, there is limited evidence 
supporting the efficacy of pharmacological treatments for MS-related cognitive dysfunction99. 
Further, the heterogeneous experience of the disease calls for the need for alternative approaches 
for managing cognitive impairment in persons with MS. Based on the notion of cognitive-motor 
coupling, one such approach involves exercise. 
  Cognitive dysfunction is prevalent in persons with MS, yet little is known regarding the 
effects of exercise on cognitive functioning in this population. In persons with MS, better 
cardiorespiratory fitness is significantly correlated with faster cognitive processing speed, but not 
measures of learning and memory100,101. Further, slower cognitive processing speed is associated 
with worse cardiorespiratory fitness, worse balance, and greater knee extensor asymmetry in 
 36 
persons with MS102. In a recent RCT, various aerobic exercise modalities and their effects on 
cognition were assessed in 42 persons with progressive MS who had moderate to severe 
disability12. Participants underwent a cycling, arm ergometry, or rowing exercise intervention for 
two to three times per week at 120-130% of their anaerobic threshold for 8-10 weeks. Cognitive 
processing speed, verbal learning and memory, attention, executive functioning, and verbal 
fluency were assessed pre- and post-intervention. Participants who underwent cycle ergometer 
training, but not the other two modalities, demonstrated significant improvements in 
cardiorespiratory fitness and verbal learning and memory. Exercise-related fitness has also been 
significantly associated with better executive control in persons with MS who have mild 
disability99. Following light, moderate, and vigorous intensity treadmill walking as compared to 
rest, interfering stimuli cost less in reaction time, but not accuracy on an inhibitory control task 
for persons with MS who have mild disability91. Interestingly, it does appear that disability status 
may moderate the relationship between physical activity and cognition103. In a study including 
persons with mild, moderate, and severe MS disability, disability status moderated associations 
between cardiorespiratory fitness and cognitive processing speed in only persons with mild 
disability103. The literature suggests that there may be various exercise-related benefits for 
different aspects of cognitive functioning in persons with MS across the disability spectrum. 
Thus, it is important to identify exercise prescriptions that maximize these benefits while being 
appropriate for all disability levels in persons with MS. 
 
Physiological and Functional Responses to Acute HIIT 
 The within-session physiological and functional responses to HIIT have been examined 
previously in healthy adult, heart disease, and stroke populations36. One recent study involving 
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stroke patients aimed at defining the optimal HIIT protocol for targeting motor recovery and 
aerobic deconditioning compared within-session exercise responses of three different HIIT 
protocols36. The repeated-measures study included 19 ambulatory persons with chronic stroke 
(>6 months after stroke). All exercise was performed on a motorized treadmill and a graded 
maximal exercise test was performed at baseline to determine each participant’s maximal speed 
in 0.1 mph increments.  The three HIIT protocols included the same work period of 30s at 
maximal walking speed, but varied the rest periods to 30s, 60s, and 120s. All exercise sessions 
included a 5-minute warm-up, 20-minutes of HIIT, and a 5-minute cool-down. As such, the work 
between protocols was not matched with the total time of work lasting for 10 minutes, 6.5 
minutes, and 4 minutes for the 30s, 60s, and 120s HIIT protocols, respectively36.  
 The researchers utilized exercise tolerance (i.e., successful completion of the prescribed 
HIIT protocol), peak oxygen uptake, heart rate reserve (HRR), peak treadmill speed, and step 
count as their primary outcome measures36. The percentage of participants who successfully 
tolerated each of the 30s, 60s, and 120s recovery HIIT protocols were 61%, 83%, and 100%, 
respectively. The 30s and 60s recovery HIIT protocols lead to significantly more time spent at or 
above moderate and vigorous aerobic intensity, measured as greater than or equal to 40% and 
60% of VO2peak or HRR, as compared to the 120s recovery HIIT protocol. The 30s and 60s 
recovery protocols were not significantly different for time spent at moderate and vigorous 
intensity; however, participants spent significantly more time at or above 85% of VO2peak (i.e., 
very hard aerobic intensity) during the 30s recovery protocols than during the 60s and 120s 
recovery protocols. The 60s recovery protocol induced significantly more time spent at or above 
85% VO2peak as compared to the 120s recovery protocol. Significant differences were evident 
across all of the protocols for mean aerobic intensity (VO2peak and HRR). The highest intensities 
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were reported for the 30s recovery protocol (70.9% VO2peak, 76.1% HRR), followed by the 60s 
protocol (63.3% VO2peak, 63.1% HRR), and the 120s protocol (47.5% VO2peak, 46.3% HRR) 
yielded the lowest values. The 30s recovery HIIT protocol yielded the highest average step 
counts (1619 steps), but at the expense of exercise tolerance and treadmill speed (1.03 m/s) as 
compared to the 60s (1.13 m/s) and 120s (1.10 m/s) recovery HIIT protocols. The 60s recovery 
protocol exhibited higher step counts (1370 steps) comparable to the 120s recovery protocol 
(1091 steps). Thus, a combination of the 30s and 60s protocol may be the ideal protocol for this 
stroke population and other neurological populations, like MS, due to its potential to optimize 
aerobic intensity, treadmill speed (i.e., work rate), stepping repetition, and exercise tolerance. 
The authors further note that this type of protocol may lead to enhanced improvements in aerobic 
outcomes and gait outcomes in future studies36.  
One group of researchers recently examined the in-session and recovery physiological 
and perceptual responses of persons with MS to varying intensities of cycling exercise37. This 
crossover exposure-response design included 11 persons with MS and 8 healthy controls. 
Initially, all participants completed a graded maximal exercise test on a cycle ergometer to 
determine their peak power output (Wpeak). Three exercise protocols were compared: 1) 
continuous cycling at 45% Wpeak, 2) continuous cycling at 60% Wpeak, 3) HIIT with 30s cycling 
at 90% Wpeak and 30s rest. The three sessions of exercise were completed in a random order, 
separated by 7 days. During each exercise session, heart rate, ratings of breathing and leg 
perceived exertion were measured every two-minutes before, during, and after the exercise 
session for a 45-minute recovery period. Tympanic temperature was measured before exercise 
and every two to five minutes during the recovery period37.  
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The data revealed no significant differences in HR responses to exercise between persons 
with MS and controls and a significant effect of the exercise on HR for all intensities (i.e., HR 
increased during exercise, then decreased during the recovery period)37. During the recovery 
period, persons with MS required 15 minutes longer than controls for their heart rate to return to 
baseline following the 45% session. Following the 60% session, the HR of both controls and 
persons with MS did not return to baseline. A recovery of 30 minutes was required for HR levels 
to return to normal for both groups following the 90% session37. There were no significant 
differences between groups in terms of in-exercise ratings of breathing and leg perceived 
exertion. During recovery, persons with MS took longer to recover in terms of perceived 
breathing and leg exertion than controls and the length of recovery increased with the increasing 
intensity of the sessions. A significant increase in temperature occurred for persons with MS 
during the 60% (Baseline: 36.7±0.4 °C, peak 37.1±0.6 °C, p>0.001) and 90% (Baseline: 
36.6±0.4 °C, peak 36.9±0.5 °C, p ¼ 0.001) sessions, but not the 45% session (Baseline: 36.7±0.4 
°C, peak 37.0±0.5 °C, p=0.112). The recovery period for temperature was 35 minutes and 25 
minutes for the 60% and 90% sessions, respectively, in persons with MS. Relative to 
temperature, there were no significant differences between exercise intensities or group at each 
intensity37.  
The previous is not without limitations37. First, the participants were not characterized 
using a standard disability measure like the EDSS or PDDS. Without this information, it is 
difficult to extrapolate these findings to all persons with MS. Further, tympanic temperature, 
which can be affected by technique, was utilized instead of core temperature. The perceived 
exertion measures of breathing and leg fatigue were not combined with objective measurements 
like cardiorespiratory (e.g. VO2, RER, and VE) and walking outcomes (e.g. T25FW and gait 
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outcomes). The small sample size is a further limitation. A post-hoc analysis of the MS group’s 
data identified moderate effect sizes between ~0.55 and 0.65; although effect sizes for each 
outcome were not provided directly in the manuscript. The authors postulated that a sample size 
of 30 would statistically confirm their reported data from the relatively small sample37. These 
two, acute, within-session studies indicate that HIIT training is safe and tolerable in neurological 
populations, like MS and stroke36,37. 
 
THE PRESENT STUDY 
 
The use of acute (i.e., single session) exercise research designs are critical for optimizing 
exercise protocols pragmatically, safely, efficiently, and from a sound design perspective. From a 
pragmatic perspective, data from acute, pilot studies can be used to develop, adapt, and identify 
the feasibility of the proposed methodology. Further, power analyses can utilize effect size and 
outcome data to generate sample sizes for larger RCTs. Valuable resources and time can be 
maximized through the implementation of an acute study to ensure the proposed methodology 
has a potentially large impact. The critical assumption, however, is that acute effects of single 
bouts of exercise are cumulative in nature resulting in an increase in aerobic fitness during 
longitudinal exercise studies104. From a safety perspective, acute exercise research designs 
ensure the safety and feasibility for exercise within a clinical population and parallel the first 
phase in a registered clinical trial105.  
Research using exercise to induce physical and functional improvements in persons with 
MS is directly related to the NIH’s mission to reduce burdens of disability38. Many exercise 
interventions are designed for persons without walking impairment and use treadmill or cycle 
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ergometers, which may not be appropriate for those with mobility impairments39. The ACSM has 
recommended recumbent stepping as an appropriate and viable assessment tool for evaluating 
aerobic fitness in neurological disorders40 and a recent study has confirmed its efficacy for 
fitness assessment in MS66. In that study, cardiorespiratory fitness assessment via the NuStep 
yielded higher peak aerobic capacity than arm ergometry39. Utilizing NuStep-based peak aerobic 
capacity will allow for exercise prescriptions set at substantially higher workloads in an effort to 
maximize physiological adaptations39 and enhance physical performance. Ideally, participants 
will achieve higher intensities during training via the NuStep with the proposed method. Some 
researchers suggest that exercising at higher intensities could benefit persons with MS19–22; yet, 
the CPAG are reflective of the minimum dosage to achieve health benefits in persons with MS. 
Thus, the proposed methodology seeks to shift the current exercise guidelines to incorporate a 
more appropriate exercise modality and intensity for persons with MS who have mobility 
impairments. This is particularly relevant in clinical practice because it provides persons with 
moderate to severe disability, who are the most deconditioned and experience limited success 
with typical pharmacological methods39,106,107, with the ability to improve physiological and 
clinically relevant functioning. 
The proposed low-volume HIIT protocol, which requires only 10 minutes of exercise 
performed over 20 minutes in a 1:1 work:rest ratio, has provided the same benefits (e.g. rapid 
skeletal muscle remodeling towards a more oxidative phenotype) to healthy participants as the 
traditional HIIT model29. HIIT has improved endurance performance and muscle strength to a 
greater degree than endurance exercise in persons with mild to moderate disability in MS19 and 
enhanced functional recovery in stroke patients28. Accordingly, the combined low-volume HIIT 
training protocol via the NuStep may be fruitful in providing benefits equivalent to traditional 
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aerobic exercise to persons with MS with mobility impairments while using an appropriate 
aerobic exercise modality39.  
The primary hypothesis was that the HIIT condition would induce significantly higher 
and oscillating patterns of physiological (i.e., VO2, VCO2, RER, VE, and HR) and perceived 
tolerance data (i.e., RPE, arm pain, and leg pain) as compared to the relatively stable data from 
the CPAG condition. Core temperature was hypothesized to increase significantly higher during 
the HIIT condition as compared to the CPAG condition. It was further hypothesized that all 
participants would be able to complete all exercise sessions as prescribed. The secondary 
hypothesis was pre- to post-exercise negative effects would be significantly larger following the 
HIIT condition as compared to the CPAG condition on functional (i.e., walking speed, 
spatiotemporal aspects of gait, and cognition), mood, and enjoyment outcomes. It was further 
hypothesized that these negative effects would dissipate after the 30-minute recovery period. 
The present study aimed to assess and compare the feasibility and physiological and 
functional effects of acute sessions of HIIT and CPAG aerobic exercise performed on a 
recumbent stepper in persons with MS with mobility impairments. The proposed methodology 
would drive the field towards an exercise prescription appropriate for persons with MS with 
walking impairments. Results from this study will likely lead to larger RCTs based on the FITT-
VP principal that will inform the current exercise prescriptions developed for improving 
physiological and clinically relevant outcomes in adults with multiple sclerosis18. This research 
is the first to examine the acute effects of HIIT as compared to the CPAG with the explicit 
purpose of designing exercise prescriptions grounded in the FITT-VP principal for improving 








 Participants were recruited through advertisements on the website of the Exercise 
Neuroscience Research Lab. We used telephone and email to recruit individuals who have 
inquired about previous research studies. These individuals have provided prior consent to be 
contacted for future research opportunities related to exercise and multiple sclerosis. Participants 
who met the following criteria were included: (a) age 18-64 years; (b) a self-reported diagnosis 
of MS; (c) self-reported Expanded Disability Status Scale (EDSS) score between 4.0 and 8.0 or 
Patient Determined Disability Steps (PDDS) scale score between 3.0 and 7.0; (d) relapse free in 
past 30 days; (e) willing and able to visit the University of Illinois at Urbana-Champaign on three 
testing occasions; (f) asymptomatic status for maximal exercise testing; and (g) physician 
approval for undertaking exercise testing. Participants who did not meet those criteria were 
excluded from study participation. The power analysis utilized reported effect sizes (i.e., ~.55-
.65) for detecting a difference between exercise intensities from research on acute physiological 
and perceptual responses to three varying intensities of exercise in MS37. According to a power 
analysis108,109 for a 2×3 repeated measures ANOVA with 10 comparisons (oxygen consumption, 
heart rate, core temperature, spatiotemporal parameters of gait, walking speed, training session 
tolerance, ratings of perceived exertion, ratings of perceived pain, mood, and cognition), a total 
sample size of 18 participants was needed to detect large effects(1 – β=0.8) with an alpha at 0.05.  
 The study flow diagram is presented in Figure 1. Sixty-seven prospective participants 
were contacted. Twenty-eight participants either did not return contacts or were not interested. 
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Of those interested, four were unable to walk 25-feet and two responded with more than two 
“yes” answers to the PAR-Q and were therefore excluded from the study. Of the 22 prospective 
participants who qualified and were subsequently enrolled in the study, two participants dropped 
out before their informed consent and baseline testing sessions. One dropout participant 
sustained a non-study related physical injury and was no longer able to walk 25-feet. The 
neurologist of the other dropout participant refused to provide physician’s approval and MS 
verification. Thus, the final sample size included 20 ambulatory persons with MS with EDSS 
scores of 4.0-6.5 (i.e., walking impairments evident with or without assistance).  
 In order to fully describe the sample in terms of their overall health, exercise behavior 
and clinical symptoms, participants completed a demographic questionnaire, exercise history 
questionnaire, the Physical Activity Readiness Questionnaire (PARQ)110, the Godin Leisure-
Time Exercise Questionnaire (GLTEQ)111, the International Physical Activity Questionnaire 
(IPAQ)112, the Short-Form (36) Health Survey (SF-36)113, Exercise Self-Efficacy Questionnaire 
(EXSE)114, Fatigue Severity Scale (FSS)115, Multiple Sclerosis Walking Scale (MSWS-12)5, and 
the Patient Determined Disease Steps (PDDS)116. All participants underwent a neurological exam 
by a Neurostatus-certified examiner to generate Expanded Disability Status Scale (EDSS)47 score 
for describing the disability status of the sample.  
 
WITHIN-SESSION PRIMARY OUTCOMES 
  
Cardiorespiratory Outcomes  
Expired gases was collected using a 2-way non-rebreathable valve (Hans Rudolph, 
Kansas City, MO, USA) and oxygen consumption will be continuously measured using an open 
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circuit spirometry system (TrueOne, Parvo Medics, Sandy, UT, USA). Verified concentrations of 
gases were used to calibrate the O2 and CO2 analyzes. A 3 L syringe (Hans Rudolph, Kansas 
City, MO, USA) was used to calibrate the flow meter. Volumes of oxygen uptake (VO2, 
mL/kg/min) carbon dioxide production (VCO2, L/min), ventilation (VE, L/min), and respiratory 
exchange ratio (RER) were measured continuously by the open-circuit spirometry system and 
expressed as 1-minute averages during all exercise sessions.  
During the baseline session, participants had their peak aerobic capacity assessed with an 
incremental cardiopulmonary exercise test (CPET). Peak aerobic capacity was assessed using a 
recumbent stepper (NuStep T5XR recumbent stepper; NuStep Inc, Ann Arbor, MI, USA)39. 
Participants were initially fitted to the recumbent stepper and subsequently read standardized 
instructions for completing the maximal aerobic capacity test. Participants completed a 1-minute 
warm-up at 15W. The initial work rate was set to 15W and was gradually increased until the 
participant reached volitional fatigue. The work rate was increased by 10W per minute and 5W 
per minute for participants with mild to moderate and severe disability, respectively. Heart rate 
using Polar FT1 heart rate monitors and ratings of perceived exertion via the Borg Rating of 
Perceived Exertion Scale (RPE) were recorded every minute. The highest recorded 30-second 
VO2 value was recorded as VO2peak, expressed in mL/kg/min, when at least 1 of the following 
criteria was satisfied: (1) respiratory RER 1.10 or greater; (2) peak heart rate within 10 beats per 
minute of age-predicted maximum (i.e., 220-age); or (3) RPE 17 or greater. The highest recorded 
power achieved was recorded as peak power output (Wpeak). This CPET protocol has been 
validated in persons with MS previously39.  
During the HIIT and CPAG sessions, VO2, VCO2, VE, and RER were recorded every 
minute and the highest 30-second averaged values of VO2, VCO2, VE, and RER were recorded 
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as Wpeak, VO2peak, VCO2peak, VEpeak, and RERpeak. Power output data was collected from the 
NuStep every minute following the warm-up until termination. The highest recorded power 
achieved will be recorded as peak power output (Wpeak). 
 
Heart Rate  
Heart rate was measured continuously and expressed as 1-minute averages during all 
sessions using a Polar FT1 heart rate monitor (Polar Electro Oy, Kempele, Finland).  
 
Core Temperature 
Participants were given ingestible and disposable core temperature sensors (CorTrack II 
system, HQ Inc., FL, USA) in capsules after the baseline session as a measure of core body 
temperature (CTemp). Participants were asked to swallow one capsule 6-12 hours before each 
session, and refrain from eating or drinking alcohol or caffeine at least 3 hours prior to each 
session. The ingestible sensor capsules wirelessly transmitted CTemp (°C) to a wireless 
physiological data recorder while traveling through the digestive tract. CTemp was recorded 
every minute throughout the HIIT and CPAG sessions.  
 
Ratings of Perceived Exertion 
Ratings of perceived exertion (RPE) were measured using the Borg RPE scale117. This 
scale ranges from 6 to 20, representing no exertion to maximal exertion. RPE data were collected 
from the participant every minute following the warm-up until termination during the 
cardiopulmonary exercise test and all HIIT and CPAG sessions.  
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Arm & Leg Pain 
Ratings of perceived arm and leg pain were measured using the Borg Scale of Perceived 
Pain117. This scale ranges from 0 to 10, representing no pain at all to very very strong pain. 
Ratings of perceived arm and leg pain were collected from the participant every minute 
following the warm-up until termination during the cardiopulmonary exercise test and all HIIT 
and CPAG sessions. 
 
PRE- AND POST-EXERCISE PRIMARY OUTCOMES 
 
Training Session Tolerance 
Training session tolerance was defined as the number of subjects who successfully 
complete each experimental session (i.e., met the required watt ranges for all sessions) and was 
expressed as a percentage of the final sample size.   
 
Timed 25-Foot Walk 
Walking speed was measured using the timed 25-foot walk (T25FW)39. Participants were 
instructed to walk as fast and as safely as possible along a clearly marked 25-foot long path on a 
carpeted surface. Using a stopwatch, one researcher recorded the participant’s time (seconds) and 
another followed alongside the participant for safety. This process was repeated twice and scores 




Spatiotemporal Gait Outcomes 
Gait-related measures were completed with two trials of walking at a self-selected pace 
on a 16-foot GAITRiteTM electronic walkway39. Velocity (cm/sec), cadence(steps/min), step time 
(seconds), step length (cm), base of support (cm), and swing (percent of cycle) were averaged for 
the two trials.  
 
Information Processing Speed 
The Symbol Digit Modalities Test (SDMT) assessment is relatively quick and valid 
within the MS population118. Participants were given 90 seconds to correctly identify as many 
symbols as possible according to a key written at the top of the examination sheet. Each symbol 
is designated by a number (1-9) in the key. The number of correctly provided numbers 
(maximum of 110) in 90 seconds was totaled for the SDMT score119. 
 
Profile of Mood States 
Participants completed the abbreviated version of the Profile of Mood States (POMS) 
questionnaire before, immediately after, and 30-minutes after each condition. This questionnaire 
consists of 30 items divided into six subscales (i.e., Tension, Depression, Anger, Fatigue, Vigor, 
and Confusion). Participants are provided with 30 adjectives, five adjectives per subscale, and 
are instructed to identify how they feel “right now.” Participants denote their response using a 5-
point Likert scale, ranging from 0 (“Not at all”) to 4 (“Extremely”). This measure is commonly 





The Physical Activity Enjoyment Scale (PACES) was used to assess the level of 
enjoyment of the HIIT and CPAG sessions123. The scale consists of 18 questions that used a 
Likert scale ranging from 1 to 7. This measure is commonly used to assess exercise-related 




Following screening and enrollment, participants were scheduled for three testing 
sessions at the Exercise Neuroscience Research Laboratory at the University of Illinois. All 
participants provided written informed consent upon arrival to the testing facility. There were 
three testing sessions: one baseline session followed by two exercise sessions. Each session was 
separated by at least 48 hours, and the order of the two sessions following the baseline session 
was randomized and counter-balanced for each participant. Participants were instructed to refrain 
from eating or drinking alcohol or caffeine at least three hours prior to each session to reduce 
interference with the core temperature pills. Except for this previous request, participants were 
instructed to maintain their “normal” dietary and hydration habits prior to each exercise session 
in order to simulate normal free-living conditions. The baseline session lasted approximately 90 
minutes. All HIIT and CPAG control sessions lasted approximately 120 minutes. Participants 





All participants upon arrival provided a written informed consent. The baseline session 
included a brief neurological exam for generation of an EDSS score, functional walking and gait 
outcomes, and an incremental exercise test (CPET) to assess peak aerobic capacity and power. 
Questionnaires were completed at the end of the baseline session. 
 
Aerobic Exercise Sessions 
Prior to the exercise protocols, participants completed the POMS, immediately followed 
by the T25FW and gait tests over the gait mat. Participants were permitted to use assistive 
devices (i.e.,, cane, walker) during the T25FW and the gait testing. Finally, participants 
completed the SDMT. These mood, walking, and cognitive assessments served as a baseline (T1) 
prior to the exercise.  
Participants underwent aerobic exercise on the NuStep completing either the 60-s HIIT 
protocol or the CPAG protocol for 30 minutes. The exercise sessions were supervised by a 
trained exercise leader who is certified in First Aid/CPR. During all exercise sessions, the 
exercise leader interacted with the participant by providing instructions, collecting data, and 
providing a slight amount of encouragement with focal, constructive feedback during all 
sessions. Volumes of oxygen uptake (VO2) carbon dioxide production (VCO2), ventilation (VE), 
and RER were measured continuously by the open-circuit spirometry system. Heart rate (HR) 
using Polar FT1 heart rate monitors and ratings of perceived exertion via the Borg Rating of 
Perceived Exertion Scale (RPE) were recorded every minute. Participants were fitted with the 
wireless CTemp data recorder prior to the exercise session. CTemp data was recorded during the 
warm-up, exercise session, and cool-down. 
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Immediately following the exercise sessions (T2), participants completed the POMS and 
PACES, underwent two more trials of the T25FW, completed two more trials of spatial and 
temporal gait testing, and completed the SDMT. These mood, walking, and cognitive 
assessments were undertaken in order to examine the acute effects of HIIT or CPAG exercise. 
Thirty minutes following the cessation of exercise or the control condition (T3), participants 
completed a third assessment of the POMS and walking measures. This third assessment of 
mood and walking was undertaken in order to examine whether the acute effects of HIIT or 
CPAG exercise are maintained 30 minutes following the completion of each condition. The 
thirty minute time period was based on previous research identifying 30 minutes of recovery 
time needed for heart rate levels to return to baseline following a HIIT protocol in persons with 
MS37.  
 
AEROBIC EXERCISE PROTOCOLS 
 
 Following the pre-exercise mood and walking performance measures, participants 
underwent aerobic exercise on the NuStep utilizing a 60-s HIIT protocol, or continuous exercise 
(CPAG) protocol. The HIIT and CPAG active exercise protocols were matched for total work 
duration and lasted for 20 minutes each. Both aerobic exercise sessions on the NuStep were 
preceded by a 5-minute warm up and followed by a 5-minute cool down. The total exercise 





The 60s HIIT protocol included 60 seconds of stepping at the workload associated with 
90% of VO2peak from the incremental CPET protocol followed by 60 seconds of active recovery 
at 15W. The bursts of vigorous exercise were interspersed with periods of active recovery for 10 
cycles, yielding an active exercise duration of 20 minutes. Participants were encouraged to 
maintain a stepping rate of 60-70 steps per minute throughout the exercise session. If participants 
could not achieve 60 steps per minute, they were encouraged to step as fast as possible, but not 
less than 40 steps per minute. 
The prescribed exercise intensity was calculated by first multiplying the desired 
percentage (i.e., 0.90) by the peak oxygen consumption (i.e., VO2peak) achieved by the participant 
during their CPET. Next, the in-exercise VO2 measurements were graphed versus the 
incremental watt ranges achieved during the CPET. The VO2 measurements were averaged over 
30s and graphed along the x-axis. The associated watt values were plotted on the y-axis. A line 
of best fit was calculated utilizing Microsoft Excel (2016) and used to predict the wattage 
associated with 90% of VO2peak. Participants were asked to achieve or surpass the calculated 
watts during the entirety of the 10, 1-minute intervals.  
  
CPAG 
The continuous aerobic exercise on the NuStep consisted of 20 minutes of continuous 
exercise at 50-60% of the peak workload from the incremental CPET protocol. This intensity 
level matches that recommended from the Canadian Guidelines for Physical Activity for Adults 
(CPAG) with MS. Participants were encouraged to maintain a stepping rate of 60-70 steps per 
 53 
minute throughout the exercise session. If participants could not achieve 60 steps per minute, 
they were encouraged to step as fast as possible, but not less than 40 steps per minute. 
The prescribed exercise intensity was calculated by first multiplying the desired 
percentage (i.e., .50 and .60) by the peak oxygen consumption (i.e., VO2peak) achieved by the 
participant during their CPET. Next, the in-exercise VO2 measurements were graphed versus the 
incremental watt ranges achieved during the CPET. The VO2 measurements were averaged over 
30s and graphed along the x-axis. The associated watt values were plotted on the y-axis. A line 
of best fit was calculated utilizing Microsoft Excel (2016) and used to predict the wattage 
associated with 50% and 60% of VO2peak. Participants were asked to exercise within the 




All data were analyzed using SPSS software version 24 (IBM corporation, Armonk, NY). 
The data were assessed for normality violations, outliers, and errors. Significant differences 
between the HIIT and CPAG protocols were determined using a repeated-measures, 2-factor 
analysis of variance (RM ANOVA) with condition (HIIT, CPAG) and time as within subject 
factors. The within-session measures (i.e., cardiorespiratory outcomes, heart rate, core 
temperature, RPE, and arm and leg pain) had 30 time-points, whereas the functional (i.e., 
T25FW, spatiotemporal gait outcomes, and SDMT) and mood-related outcomes (POMS) had 
three time points. Estimated Marginal Means adjusted for multiple comparisons with Least 
Significant Difference were used to analyze significant main effects from the 2 u 3 RM 
ANOVAs for the functional and mood outcomes. Overall effect sizes from the RM ANOVAs 
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were expressed as partial eta-squared. Small, medium, and large effects were interpreted as 
partial eta-squared values of 0.01, 0.06, and 0.14, respectively125. Follow-up paired t-tests were 
used to analyze significant interactions from the 2 u 3 RM ANOVA analyses. Paired t-tests were 
also used to compare the peak and average physiological and perceptual tolerance outcomes and 
PACES scores between the HIIT and CPAG conditions. Effect sizes were expressed as Cohen’s 
d. Small, medium, and large effects were interpreted as Cohen’s d values of 0.2, 0.5, and 0.8, 








The descriptive demographic, clinical, health, and activity characteristics of the sample 
are listed in Table 1. On average, participants were 55.1 (7.4) years of age, mostly female (85%), 
had some college (35%) or were college graduates (30%), and were unemployed (90%). RRMS 
was the dominant disease type (65%), but progressive MS was also represented in the sample 
(35%). Participants had an average disease duration of 17.2 (10.3) years. The median (IQR) 
EDSS score was 5.8 (0.8), indicating a sample with ambulatory impairment47. Participants, on 
average, exercised for at least 30 minutes at a moderate or strenuous intensity for 2.9 (1.2) days 
per week and scored a 24.5 on the GLTEQ, signifying that participants were sufficiently active 
according to physical activity recommendations111,127. All participants successfully met at least 1 
of the 3 criteria for determining ?̇?O2peak during the graded maximal exercise test. The sample’s 
mean aerobic capacity was 14.7 (15.2) ml/kg/min, which is comparable to other samples of 
person’s MS with moderate disability39. 
One participant was unable to complete the HIIT session as prescribed in its entirety. 
This participant mostly utilized a wheelchair as an assistive device and the walking and gait 
outcomes themselves seemed to induce fatigue in this particular participant. This participant 
completed the warm-up, 4 of the 10 interval cycles, and the cool-down of the HIIT session. All 
functional and mood outcomes performed pre-, immediately post-, and 30-minutes post-exercise 
were performed by this participant. Thus, this participant’s data has been removed from the 
within-exercise data of the primary physiological and perceived training session tolerance (i.e., 
 56 
RPE and arm and leg pain) analyses. Core temperature data was included for only 16 participants 
due to equipment error and incomplete data. 
 
MANIPULATION CHECK BASED ON POWER OUTPUT 
  
In order to determine the power output prescription for each participant, the in-exercise 
VO2 and incremental watt data collected during the CPET were graphed as a scatter plot. A line 
of best fit was calculated to predict the wattage for the HIIT and CPAG aerobic exercise 
sessions. The mean R2 value for this line of best fit representing the association between oxygen 
consumption and power output during the CPET was .89 (.09). The mean prescribed power 
outputs for the overall sample were 68.3 (25.0) W and 29.6 (13.6) W for the 90% HIIT intervals 
and CPAG sessions, respectively. The mean power outputs for the 90% HIIT intervals and 
CPAG conditions were 72.7 (26.7) W and 32.5 (15.1) W, respectively. A paired samples t-test 
indicated that there was a statistically significant difference in prescribed (~68 W) and actual 
power output (~73 W) for the 90% HIIT intervals; t(19) = 9.26, p < .001, indicating that 
participants during the high-intensity intervals were working at a significantly higher power than 
prescribed. A paired samples t-test indicated that there was no significant difference in 
prescribed (~30 W) and actual power output (~33 W) for the CPAG exercise session; t(19) = -




WITHIN-SESSION PRIMARY OUTCOMES 
 
Descriptive data for the peak and average physiological and training session tolerance 
primary outcomes collected during the HIIT and CPAG sessions are presented in Tables 2 and 3, 
respectively. The summaries of the separate 2 u 30 repeated measures ANOVAs on the power 
output, cardiorespiratory, heart rate, and core temperature outcomes are located in Tables 4, 5, 6, 
and 7, respectively. The summaries of the separate 2 u 30 repeated measures ANOVAs on the 
ratings of perceived exertion and arm and leg pain outcomes are located in Tables 8, and 9, 
respectively. 
 
Training session tolerance 
 Of the 20 participants in the sample who partook in the study, only one participant was 
unable to complete the HIIT session as prescribed. All participants completed the CPAG sessions 
as prescribed. Thus, the HIIT and CPAG training session tolerance levels were 95% and 100%, 
respectively. No adverse events occurred during the exercise sessions.  
 
Cardiorespiratory Outcomes 
 Power Output. Figure 2 illustrates the acute effects of HIIT and CPAG NuStep aerobic 
exercise sessions on power output. The 2 u 30 repeated measures ANOVA indicated an overall 
large, statistically significant condition u time interaction, F(29,522) = 79.72, p < .001, 𝜂𝑝2 = 
.82, on power output, with participants producing significantly more power during the active 
exercise of the HIIT session. The data further indicated a statistically significant, large, main 
effects of condition, F(1,18) = 90.35, p < .001, 𝜂𝑝2 = .83, and time, F(29,522) = 66.05, p < .001, 
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𝜂𝑝2 =.79, on power output. The significant interaction indicates a differential pattern of power 
output over time in the HIIT versus CPAG condition. The pattern for HIIT was periodic with 
peaks and valleys corresponding to the high-intensity and recovery intervals; whereas the pattern 
for the CPAG condition was relatively stable. On average, power output was 43.9 (13.3) W 
during the HIIT sessions, which was significantly higher than the 32.5 (15.1) W during the 
CPAG session (p<.001). The significant main effect of condition indicates, irrespective of time, 
that power output differed between conditions with higher power output occurring during the 
HIIT condition as compared to the CPAG condition. The significant main effect of time 
indicates, irrespective of condition, that power output was higher during different phases of the 
exercise sessions. Power output was lower during the warm-up and cool-down, and higher 
during active exercise, regardless of the HIIT or CPAG condition.  
VO2. Figure 3 illustrates the acute effects of HIIT and CPAG NuStep aerobic exercise 
sessions on relative oxygen consumption. The 2 u 30 repeated measures ANOVA indicated an 
overall large, statistically significant condition u time interaction, F(29,522) = 18.96, p < .001, 
𝜂𝑝2 = .51, on oxygen consumption. The data further indicated statistically significant, large, 
main effects of condition, F(1,18) = 70.09, p < .001, 𝜂𝑝2 = .80, and time, F(29,522) = 63.33, p < 
.001, 𝜂𝑝2 =.51, on oxygen consumption. The significant interaction indicates a differential 
pattern of oxygen consumption over time in the HIIT versus CPAG condition. There were no 
significant differences between conditions in the relative volume of oxygen consumed during the 
warm-up. The volume of oxygen consumed during the active exercise of the HIIT and CPAG 
sessions increased significantly during the first three minutes, then remained relatively stable 
until the cool-down. However, on average, participants consumed 11.0 (3.6) ml/kg/min of 
oxygen during the active exercise of the HIIT sessions, which was significantly higher than the 
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9.3 (3.2) ml/kg/min of oxygen consumed during active exercise of the CPAG session (p<.001). 
The volume of oxygen consumed during the first two minutes of the cool-down remained higher 
for the HIIT session as compared to the CPAG, but relative oxygen consumption converged 
during the last three minutes of the cool-down. Thus, the significant interaction was likely due to 
the pattern of higher of oxygen consumption for the HIIT condition versus the CPAG condition 
during active exercise and the initial minutes of the cool-down. The significant main effect of 
condition indicates, irrespective of time, that oxygen consumption differed between conditions 
with higher oxygen consumption occurring during the HIIT condition as compared to the CPAG 
condition. The significant main effect of time indicates, irrespective of condition, that oxygen 
consumption was higher during different phases of the exercise sessions. Oxygen consumption 
increased during the warm-up, remained relatively stable during the active exercise, and 
decreased during the cool-down, regardless of the HIIT or CPAG condition. 
VCO2. Figure 4 illustrates the acute effects of HIIT and CPAG NuStep aerobic exercise 
sessions on carbon dioxide expiration. The 2 u 30 repeated measures ANOVA indicated an 
overall large, statistically significant condition u time interaction, F(29,522) = 21.34, p < .001, 
𝜂𝑝2 = .54, on carbon dioxide expiration. The data indicated statistically significant, large, main 
effects of condition, F(1,18) = 65.98, p < .001, 𝜂𝑝2 = .79, and time, F(29,522) = 55.95, p < .001, 
𝜂𝑝2 =.76, on carbon dioxide expiration. The significant interaction indicates a differential pattern 
of carbon dioxide expiration over time in the HIIT versus CPAG condition. There were no 
significant differences in the volume of carbon dioxide expiration during the warm-up. It is clear 
that during the initial two-minutes of active exercise, carbon dioxide expiration was not 
significantly different between conditions, but deviated each minute following until the last two 
minutes of the cool-down. The pattern for the HIIT session was periodic with slight peaks and 
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valleys corresponding to the high-intensity and recovery intervals; whereas the pattern for the 
CPAG condition remained relatively stable. On average, participants expired 0.8 (0.3) L/min of 
carbon dioxide during the HIIT sessions, which was significantly higher than the 0.7 (0.2) L/min 
of carbon dioxide expired during the CPAG session (p<.001). The volume of carbon dioxide 
expired during the first three minutes of the cool-down remained higher for the HIIT session as 
compared to the CPAG session, but relative carbon dioxide expiration converged during the last 
two minutes of the cool-down. Thus, the significant interaction was likely due to the pattern of 
higher of carbon dioxide expired for the HIIT condition as compared to the CPAG condition 
during active exercise and the initial minutes of the cool-down. The significant main effect of 
condition indicates, irrespective of time, that carbon dioxide expiration differed between 
conditions with higher carbon dioxide expiration occurring during the HIIT condition as 
compared to the CPAG condition. The significant main effect of time indicates, irrespective of 
condition, that carbon dioxide expiration was higher during different phases of the exercise 
sessions. Carbon dioxide expiration increased during the warm-up, remained relatively stable 
during the active exercise, and decreased during the cool-down, regardless of the HIIT or CPAG 
condition. 
RER. Figure 5 illustrates the acute effects of HIIT and CPAG NuStep aerobic exercise 
sessions on RER. The 2 u 30 repeated measures ANOVA indicated an overall large, statistically 
significant interaction effect between condition and time, F(29,522) = 14.32, p < .001, 𝜂𝑝2 = .44, 
on RER. The data further indicated statistically significant, large, main effects of condition, 
F(1,18) = 20.97, p < .001, 𝜂𝑝2 = .54, and time, F(29,522) = 48.77, p <.001, 𝜂𝑝2 = .73, on RER. 
The significant interaction indicates a differential pattern of RER over time in the HIIT versus 
CPAG condition. There were no significant differences between the HIIT and CPAG warm-up 
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RERs, which included an initial rise, subsequent decrease, and then gradual increase into the 
active exercise. The RER values for the HIIT and CPAG conditions were not significantly 
different during the first two minutes of active exercise. The RER data then diverged by 
condition. The pattern for HIIT during active exercise was periodic with peaks and valleys 
corresponding to the high-intensity and recovery intervals; whereas the pattern for the CPAG 
condition was relatively stable. On average, the HIIT session produced significantly higher RER 
values than the CPAG active exercise (p<.001) with RERs of 1.0 (0.0) and 0.9 (0.1), 
respectively. During the cool-down period, both sessions had an initial rise in the RER that was 
followed by a decline until termination. The HIIT RER data were significantly higher than those 
of the CPAG session during the entirety of the cool-down. The significant main effect of 
condition indicates, irrespective of time, that RER differed between conditions with higher RER 
occurring during the HIIT condition as compared to the CPAG condition. The significant main 
effect of time indicates, irrespective of condition, that RER was higher during different phases of 
the exercise sessions. RER was lower during the warm-up, higher during active exercise, and 
declined after initial increases during the cool-down, regardless of the HIIT or CPAG condition. 
 VE. Figure 6 illustrates the acute effects of HIIT and CPAG NuStep aerobic exercise 
sessions on minute ventilation. The 2 u 30 repeated measures ANOVA indicated an overall 
large, statistically significant condition u time interaction, F(29,522) = 15.02, p < .001, 𝜂𝑝2 = 
.45, on minute ventilation. The data further indicated statistically significant, large, main effects 
of condition, F(1,18) = 49.03, p <.001, 𝜂𝑝2 = .73, and time, F(29,522) = 51.19, p < .001, 𝜂𝑝2 = 
.74, on minute ventilation. The significant interaction indicates a differential pattern of minute 
ventilation over time in the HIIT versus CPAG condition. There were no significant differences 
in the minute ventilation during the warm-up. It is clear that during the initial two-minutes of 
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active exercise, minute ventilation was not significantly different between conditions, but 
deviated each minute following until the last two minutes of the cool-down. The pattern for the 
HIIT session was periodic with slight peaks and valleys corresponding to the high-intensity and 
recovery intervals; whereas the pattern for the CPAG condition remained relatively stable. On 
average, participants had a minute ventilation of 29.9 (8.8) L/min during the HIIT sessions, 
which was significantly higher than the minute ventilation of 24.1 (6.8) L/min during the CPAG 
session (p<.001). Minute ventilation gradually decreased for both conditions during the cool-
down; however, minute ventilation was significantly higher for the HIIT condition as compared 
to the CPAG condition. Thus, the significant interaction was likely due to the pattern of higher 
minute ventilation for the HIIT condition versus the CPAG condition during active exercise and 
the cool-down. The significant main effect of condition indicates, irrespective of time, that 
minute ventilation differed between conditions with a higher minute ventilation occurring during 
the HIIT condition as compared to the CPAG condition. The significant main effect of time 
indicates, irrespective of condition, that minute ventilation was higher during different phases of 
the exercise sessions. Minute ventilation increased during the warm-up, remained relatively 




Figure 7 illustrates the acute effects of HIIT and CPAG NuStep aerobic exercise sessions 
on HR. The 2 u 30 repeated measures ANOVA indicated an overall large, statistically significant 
condition u time interaction, F(29,522) = 22.16, p < .001, 𝜂𝑝2 = .55, on HR. The data indicated a 
statistically significant, large, main effect of condition, F(1,18) = 9.25, p =.01, 𝜂𝑝2 = .34, on HR. 
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There was a statistically significant, large, main effect of time, F(29,522) = 63.65, p < .001, 𝜂𝑝2 
= .78, on HR. The significant interaction indicates a differential pattern of HR over time in the 
HIIT versus CPAG condition.  HR was not significantly different during the warm-up. During 
the active exercise of the HIIT session, an initial increase in HR is evident that is followed by an 
oscillating pattern corresponding to the high-intensity and recovery portions of the HIIT exercise 
protocol. The average HR for the HIIT session was 112.5 (16.0) beats per minute. HR during the 
active exercise of the CPAG session gradually increased and plateaued with an average of 106.5 
(15.2) beats per minute. On average, HR was significantly different between conditions (p<.01). 
The HR for both conditions gradually decreased during the cool-down and were not significantly 
different after the third minute of the cool-down. Thus, the significant interaction was likely due 
to the pattern of higher HR for the HIIT condition as compared to the CPAG condition during 
active exercise and the cool-down. The significant main effect of condition indicates, irrespective 
of time, that HR differed between conditions with a higher HR occurring during the HIIT 
condition as compared to the CPAG condition. The significant main effect of time indicates, 
irrespective of condition, that HR was higher during different phases of the exercise sessions. HR 
increased during the warm-up, remained relatively stable during the active exercise, and 
decreased during the cool-down, regardless of the HIIT or CPAG condition. 
 
Core Temperature 
Figure 8 illustrates the acute effects of HIIT and CPAG NuStep aerobic exercise sessions 
on core temperature. The 2 u 30 repeated measures ANOVA indicated an overall large, 
statistically significant condition u time interaction, F(29,435) = 2.68, p < .001, 𝜂𝑝2 = .15, on 
core temperature. There was a statistically significant, large, main effect of time, F(29,522) = 
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7.85, p < .001, 𝜂𝑝2 = .34, on core temperature. The main effect of condition, F(1,16) = 0.27, p = 
.61, 𝜂𝑝2 = .02, on core temperature was not statistically significant. The significant interaction 
indicates a differential pattern of core temperature over time in the HIIT versus CPAG condition. 
The significant interaction effect likely occurred at minute 16, where core temperature appears to 
be significantly higher for the HIIT condition than the CPAG condition. However, upon formal 
follow-up using a paired samples t-test for minute 16, there were no significant differences 
between conditions; t(15) = 1.43, p = .17. The non-significant main effect of condition indicates, 
irrespective of time, that core temperature did not differ between conditions. The significant 
main effect of time indicates, irrespective of condition, that core temperature was higher during 
different phases of the exercise sessions. Over time, core temperatures rose from warm-up to 
cool-down for both the HIIT and CPAG exercise conditions with average core temperatures of 
37.4 (0.6) °C and 37.3 (0.6) °C, respectively. On average, core temperature was not significantly 
different between conditions (p>.05). Core temperature significantly increased 0.31 °C and 0.53 
°C from minute 1 to minute 31 (p<.05) during the CPAG and HIIT exercise sessions, 
respectively. 
 
Ratings of Perceived Exertion 
 Figure 9 illustrates the acute effects of HIIT and CPAG NuStep aerobic exercise sessions 
on RPE. The 2 u 30 repeated measures ANOVA indicated an overall large, statistically 
significant condition u time interaction, F(29,522) = 10.03, p < .001, 𝜂𝑝2 = .36, on RPE. There 
was a statistically significant, large, main effect of time, F(29,522) = 50.34, p < .001, 𝜂𝑝2 = .74, 
on RPE. The main effect of condition, F(1,18) = .44, p = .51, 𝜂𝑝2 = .02, on RPE was not 
statistically significant. The significant interaction indicates a differential pattern of RPE over 
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time in the HIIT versus CPAG condition. Participants rated their perceived exertion as higher 
during the CPAG warm-up as compared to the HIIT-warm-up. Perceived exertion oscillated up 
and down consistently with the high-intensity and recovery intervals during the active exercise of 
the HIIT session, with a slightly increasing trend of perceived exertion during the exercise 
session until the cool-down. Perceived exertion during the CPAG session gradually increased 
over time until the cool-down. On average, RPE was not significantly different between 
conditions (p>.05). Participants rated their exertion as 10.7 (2.5) and 10.8 (3.7) during the active 
exercise of the HIIT and CPAG conditions, respectively. The interaction effects are likely due to 
the HIIT recovery RPE at minutes 6, 8, 10, 18, 20, and 22 and the HIIT high-intensity RPE at 
minutes 11 and 13. The data did not indicate a significant difference in RPE between conditions 
during the cool-down. The significant main effect of time indicates, irrespective of condition, 
that RPE was higher during different phases of the exercise sessions. RPE was lower during the 
warm-up and cool-down, and higher with gradual increases during active exercise, regardless of 
the HIIT or CPAG condition. The non-significant main effect of condition indicates, irrespective 
of time, that RPE did not differ between conditions. 
 
Arm and Leg Pain 
 Arm Pain. Figure 10 illustrates the acute effects of HIIT and CPAG NuStep aerobic 
exercise sessions on arm pain. The 2 u 30 repeated measures ANOVA indicated no significant 
condition u time interaction (F(29,522) = 1.38, p = .09, 𝜂𝑝2 = .07) and no main effect of 
condition (F(1,18) = 1.21, p =.29, 𝜂𝑝2 = .06) on arm pain. The data indicated a statistically 
significant, large, main effect of time (F(29,522) = 4.09, p < .001, 𝜂𝑝2 = .19) on arm pain. The 
non-significant interaction indicates a similar pattern of arm pain over time in the HIIT and 
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CPAG conditions. The significant main effect of time indicates, irrespective of condition, that 
arm pain was higher during different phases of the exercise sessions. Arm pain was lower during 
the warm-up and cool-down, and higher with gradual increases during active exercise, regardless 
of the HIIT or CPAG condition. On average, participants rated their arm pain as 1.1 (1.9) and 1.2 
(2.2) during the active exercise of the HIIT and CPAG conditions, respectively. The non-
significant main effect of condition indicates, irrespective of time, that arm did not differ 
between conditions. 
 Leg Pain. Figure 11 illustrates the acute effects of HIIT and CPAG NuStep aerobic 
exercise sessions on leg pain. The 2 u 30 repeated measures ANOVA indicated a statistically 
significant, medium condition u time interaction (F(29,522) = 1.71, p = .01, 𝜂𝑝2 = .09) on leg 
pain. The data indicated a statistically significant, large, main effect of time (F(29,522) = 7.78, p 
< .001, 𝜂𝑝2 = .30) on leg pain. The data indicated no significant condition (F(1,18) = 0.03, p 
=.85, 𝜂𝑝2 = .002) effect on leg pain. The significant interaction indicates a differential pattern of 
leg pain over time in the HIIT versus CPAG condition. Participants did not rate their leg pain as 
significantly different during the warm-up. Leg pain oscillated up and down consistently with the 
high-intensity and recovery intervals during the active exercise of the HIIT session, with a 
slightly increasing trend of leg pain during the exercise session until the cool-down. Leg pain 
during the CPAG session gradually increased over time until the cool-down. On average, 
participants rated their leg pain as 1.8 (2.4) and 1.7 (2.5) during the HIIT and CPAG sessions, 
respectively, which was not significantly different between conditions (p>.05). The data did not 
indicate a significant difference in leg pain between conditions during the cool-down. Thus, the 
significant interaction was likely due to the pattern of higher and lower leg pain in the HIIT 
condition versus the CPAG condition during active exercise. The significant main effect of time 
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indicates, irrespective of condition, that arm pain was higher during different phases of the 
exercise sessions. Leg pain was lower during the warm-up and cool-down, and higher with 
gradual increases during active exercise, regardless of the HIIT or CPAG condition. The non-
significant main effect of condition indicates, irrespective of time, that leg pain did not differ 
between conditions. 
 
PRE- AND POST-EXERCISE PRIMARY OUTCOMES 
 
Descriptive data for the pre- and post-exercise functional and mood primary outcomes are 
presented in Table 10. The summaries of the separate 2 u 3 repeated measures ANOVAs on the 
walking speed, spatiotemporal gait, cognitive, and mood outcomes are located in Tables 11, 12, 
13, and 14, respectively.  
 
Timed 25-Foot Walk 
 The 2 u 3 repeated measures ANOVA indicated no significant condition u time 
interaction (F(2,38) = .19, p = .83, 𝜂𝑝2 = .01) on walking speed. Walking speed did not change in 
a differential manner per exercise session across the three time points (Figure 12). The main 
effect of condition (F(1,19) = 3.84, p = .06, 𝜂𝑝2 = .17) on walking speed approached significance 
with large effects, with collapsed T25FW scores of 3.2 (0.3) ft/s and 3.1 (0.3) ft/s for the HIIT 
and CPAG conditions, respectively. The main effect of time (F(2,38) = 1.55, p =.23, 𝜂𝑝2 = .08) 




Spatiotemporal Gait Outcomes 
 Velocity. The 2 u 3 repeated measures ANOVA indicated no significant condition u time 
interaction (F(2,38) = 1.43, p = .25, 𝜂𝑝2 = .07) on gait velocity. Gait velocity did not change 
differentially per condition across the three time points (Figure 13). The data indicated a 
statistically significant, large main effect of time (F(2,38) = 4.13, p = .02, 𝜂𝑝2 = .18) on gait 
velocity. These data indicate a trend toward a differential pattern of change in gait velocity from 
pre-exercise to post-exercise and following a 30-minute rest period (i.e., T1, T2, and T3). When 
collapsed across condition, gait velocity significantly decreased from 77.9 (SE 6.9) cm/sec at T1 
to 74.4 (SE 7.0) cm/sec at T2 and significantly increased to 78.0 (SE 6.8) cm/sec at T3. T1 and 
T3 were not significantly different (p > .05). The main effect of condition (F(1,19) = 1.40, p = 
.25, 𝜂𝑝2 = .07) on gait velocity was non-significant. 
 Cadence. The 2 u 3 repeated measures ANOVA indicated statistically significant and 
large condition u time interaction (F(2,38) = 3.29, p < .05, 𝜂𝑝2 = .15, Figure 14). However, upon 
follow-up with paired t-tests, no significant differences were found at any of the time points 
between conditions (p > .05). The main effect of time (F(2,38) = 4.41, p = .02, 𝜂𝑝2 = .19) was 
significant on cadence. These data indicate a trend toward a differential pattern of change in 
cadence from pre-exercise to post-exercise and following a 30-minute rest period (i.e., T1, T2, 
and T3). When collapsed across condition, cadence significantly decreased from 86.9 (SE 5.6) 
steps/min at T1 to 83.9 (SE 5.6) steps/min at T2 and significantly increased to 86.5 (SE 5.2) 
steps/min at T3. The data indicated no significant main effect of condition (F(1,19) = 0.78, p = 
.39, 𝜂𝑝2 = .04) on cadence. 
 Step Time. The 2 u 3 repeated measures ANOVA indicated no significant interaction 
(F(2,38) = 1.85, p = .37, 𝜂𝑝2 = .09) effects on step time, demonstrating that step time did not 
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change differentially per condition across the three time points (Figure 15). The main effect of 
time (F(2,38) = 5.52, p < .01, 𝜂𝑝2 = .23) was significant on step time. These data indicate a trend 
toward a differential pattern of change in step time from pre-exercise to post-exercise and 
following a 30-minute rest period (i.e., T1, T2, and T3). When collapsed across condition, step 
time significantly increased from 0.81 (SE 0.10) seconds at T1 to 0.86 (SE 0.12) seconds at T2 
and significantly decreased to 0.80 (SE 0.10) seconds at T3. The main effect of condition 
(F(1,19) = 0.98, p = .34, 𝜂𝑝2 = .05) was non-significant. 
 Step Length. The 2 u 3 repeated measures ANOVA indicated no significant condition u 
time interaction (F(2,38) = 1.26, p = .29, 𝜂𝑝2 = .06), demonstrating that step length did not 
change differentially per condition across the three time points (Figure 16). The main effect of 
time (F(2,38) = 3.20, p = .05, 𝜂𝑝2 = .14) was significant on step length. These data indicate a 
trend toward a differential pattern of change in step length from pre-exercise to post-exercise and 
following a 30-minute rest period (i.e., T1, T2, and T3). When collapsed across condition, step 
length non-significantly decreased from 51.4 (SE 2.6) cm at T1 to 50.7 (SE 2.6) seconds at T2, 
but significantly rebounded to 52.7 (SE 2.7) cm at T3. The main effect of condition (F(1,19) = 
0.26, p = .62, 𝜂𝑝2 = .01) on step length was non-significant. 
 Base of Support. The 2 u 3 repeated measures ANOVA indicated no significant condition 
u time interaction (F(2,38) = 1.61, p = .21, 𝜂𝑝2 = .08) on base of support, demonstrating that 
base of support did not change differentially per condition across the three time points (Figure 
17). The data indicated a statistically significant, large, main effect of time (F(2,38) = 4.03, p = 
.03, 𝜂𝑝2 = .17) on base of support. These data indicate a trend toward a differential pattern of 
change in base of support from pre-exercise to post-exercise and following a 30-minute rest 
period (i.e., T1, T2, and T3). When collapsed across condition, base of support non-significantly 
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increased from 14.4 (SE 0.9) cm at T1 to 14.9 (SE 0.9) cm at T2, but significantly decreased to 
13.6 (SE 1.1) cm at T3. The main effect of condition (F(1,19) = 2.28, p = .15, 𝜂𝑝2 = .11) on base 
of support was non-significant. 
 Swing. The 2 u 3 repeated measures ANOVA indicated no significant condition u time 
interaction (F(2,38) = 0.28, p = .76, 𝜂𝑝2 = .01) on swing, demonstrating that swing did not 
change differentially per condition across the three time points (Figure 18). The data indicated a 
statistically significant, large, main effect of time (F(2,38) = 3.77, p = .03, 𝜂𝑝2 = .17) on swing. 
These data indicate a trend toward a differential pattern of change in swing from pre-exercise to 
post-exercise and following a 30-minute rest period (i.e., T1, T2, and T3). When collapsed across 
condition, swing non-significantly decreased from 29.9% (SE 1.5%) at T1 to 29.1% (SE 1.5%) at 
T2, but significantly increased to 30.2% (SE 1.4%) at T3. The main effect of condition (F(1,19) 
= 2.92, p = .10, 𝜂𝑝2 = .13) on swing was non-significant. 
 
Cognition 
 The 2 u 3 repeated measures ANOVA indicated no significant condition u time 
interaction (F(2,38) = 0.34, p = .71, 𝜂𝑝2 = .02) on information processing speed as measured by 
SDMT performance. Information processing speed did not change differentially per condition 
across the three time points (Figure 19). The data indicated a statistically significant, large, main 
effect of time (F(2,38) = 13.24, p < .001 𝜂𝑝2 = .41) on information processing speed as measured 
as SDMT performance. These data indicate a trend toward a differential pattern of change in 
information processing speed from pre-exercise to post-exercise and following a 30-minute rest 
period (i.e., T1, T2, and T3). When collapsed across conditions, information processing speed 
significantly increased from 53.0 (SE 2.1) correct responses at T1 to 56.4 (SE 2.3) at T2, and 
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continued to significantly increase to 57.9 (SE 2.5) at T3. The main effect of condition (F(1,19) = 
0.79, p = .38, 𝜂𝑝2 = .04) was non-significant. 
 
Mood States 
 Total Mood Disturbance. The 2 u 3 repeated measures ANOVA indicated no significant 
condition u time interaction (F(2,38) = 1.26, p = .29, 𝜂𝑝2 = .06) on TMD, demonstrating that 
TMD did not change differentially per condition across the three time points (Figure 20). The 
data indicated a statistically significant, large, main effect of time (F(2,38) = 4.45, p = .02, 𝜂𝑝2 = 
.19) on TMD. These data indicate a trend toward a differential pattern of change in TMD from 
pre-exercise to post-exercise and following a 30-minute rest period (i.e., T1, T2, and T3). When 
collapsed across condition, TMD non-significantly increased from 25.1 (SE 2.3) at T1 to 27.1 
(SE 1.4) at T2, but significantly decreased to 21.8 (SE 1.3) cm at T3. The main effect of 
condition (F(1,19) = 4.11, p = .06, 𝜂𝑝2 = .18) approached significance, with TMD being slightly 
higher (25.6, SE 1.6) during the CPAG session than during the HIIT session (23.7, SE 1.3).  
Fatigue. The 2 u 3 repeated measures ANOVA indicated no significant condition u time 
interaction (F(2,38) = 2.38, p = .11, 𝜂𝑝2 = .11) on fatigue, demonstrating that fatigue did not 
change differentially per condition across the three time points (Figure 21). The data indicated a 
statistically significant, large, main effect of time (F(2,38) = 11.49, p < .001, 𝜂𝑝2 = .38) on 
fatigue. These data indicate a trend toward a differential pattern of change in fatigue from pre-
exercise to post-exercise and following a 30-minute rest period (i.e., T1, T2, and T3). When 
collapsed across condition, fatigue significantly increased from 4.7 (SE 0.9) at T1 to 7.5 (SE 0.8) 
at T2 and significantly decreased to 4.2 (SE 0.8) cm at T3. The main effect of condition (F(1,19) 
= 2.19, p = .15, 𝜂𝑝2 = .10) was non-significant. 
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Vigor. The 2 u 3 repeated measures ANOVA indicated no significant condition u time 
interaction (F(2,38) = 1.65, p = .21, 𝜂𝑝2 = .08) on vigor, demonstrating that vigor did not change 
differentially per condition across the three time points (Figure 22). The data indicated a 
statistically significant, large, main effect of time (F(2,38) = 3.35, p < .05, 𝜂𝑝2 = .15) on vigor. 
These data indicate a trend toward a differential pattern of change in vigor from pre-exercise to 
post-exercise and following a 30-minute rest period (i.e., T1, T2, and T3). When collapsed across 
condition, vigor significantly decreased from 5.5 (SE 0.7) at T1 to 4.1 (SE 0.6) at T2 and non-
significantly increased to 5.0 (SE 0.7) at T3. The main effect of condition (F(1,19) = 0.06, p = 
.81, 𝜂𝑝2 < .01) was non-significant. 
Tension. The 2 u 3 repeated measures ANOVA indicated no significant condition u time 
interaction (F(2,38) = 1.31, p = .28, 𝜂𝑝2 = .06) on tension, demonstrating that tension did not 
change differentially per condition across the three time points (Figure 23). The data indicated a 
statistically significant, large, main effect of time (F(2,38) = 6.80, p < .01, 𝜂𝑝2 = .26) on tension. 
These data indicate a trend toward a differential pattern of change in tension from pre-exercise to 
post-exercise and following a 30-minute rest period (i.e., T1, T2, and T3). When collapsed across 
condition, tension significantly decreased from 1.8 (SE 0.5) at T1 to 1.6 (SE 0.3) at T2 and 
continued to significantly decrease to 0.6 (SE 0.2) cm at T3. The main effect of condition 
(F(1,19) = 0.91, p = .35, 𝜂𝑝2 = .05) on tension was non-significant. 
Anger. The 2 u 3 repeated measures ANOVA indicated no significant condition u time 
interaction (F(2,38) = 0.33, p = .72, 𝜂𝑝2 = .02), demonstrating that anger did not change 
differentially per condition across the three time points (Figure 24). The main effects of 
condition (F(1,19) = 0.89, p =.36, 𝜂𝑝2 = .04) and time (F(2,38) = 2.74, p =.08, 𝜂𝑝2 = .13) on 
anger were non-significant. 
 73 
Depression. The 2 u 3 repeated measures ANOVA indicated no significant condition u 
time interaction (F(2,38) = 1.32, p = .28, 𝜂𝑝2 = .07), demonstrating that depression did not 
change differentially per condition across the three time points (Figure 25). The main effect of 
time (F(2,38) = 3.11, p =.06, 𝜂𝑝2 = .14) on depression approached significance, with depression 
decreasing from 1.2 (SE 0.6) at T1 to 0.4 (SE 0.3) at T2 and 0.4 (SE 0.2) at T3. The main effect 
of condition (F(1,19) = 2.48, p =.13, 𝜂𝑝2 = .12) was non-significant. 
Confusion. The 2 u 3 repeated measures ANOVA indicated no significant condition u 
time interaction (F(2,38) = 1.53, p = .23, 𝜂𝑝2 = .07) on confusion, demonstrating that anger did 
not change differentially per condition across the three time points (Figure 26). The data 
indicated a statistically significant, large, main effect of time (F(2,38) = 7.09, p < .01, 𝜂𝑝2 = .27) 
on confusion. These data indicate a trend toward a differential pattern of change in confusion 
from pre-exercise to post-exercise and following a 30-minute rest period (i.e., T1, T2, and T3). 
When collapsed across condition, confusion significantly decreased from 2.5 (SE 0.4) at T1 to 
1.7 (SE 0.2) at T2 and continued to non-significantly decrease to 1.5 (SE 0.2) cm at T3. The 
main effect of condition (F(1,19) = 1.22, p = .28, 𝜂𝑝2 = .06) on confusion was non-significant. 
 
Physical Activity Enjoyment 
 There was no significant difference in scores for the PACES questionnaire for the HIIT 
(M = 95.5, SD = 14.9) and CPAG (M = 97.7, SD = 16.3) conditions; t(19) = 0.65, p = .53, 




CHAPTER 5—DISCUSSION  
  
High quality evidence suggests that traditional exercise training offers many benefits to 
persons with MS, including improvements in aerobic fitness, walking dysfunction and gait, 
balance, muscle strength and endurance, fatigue, and quality of life14,128–131. These benefits 
ultimately impact various aspects of the disease’s pathogenesis14,15. Researchers developed 
guidelines for physical activity in persons with MS (i.e., the CPAG) based on a systematic 
review and these guidelines reflect a minimum dose for health-related physical fitness16,18. Some 
researchers suggest that persons with MS could experience superior benefits from higher-
intensity exercise based on the literature in other healthy and clinical populations19–23,26–29.  
Although two, 12-week intervention studies in people with MS have identified positive benefits 
from engaging in HIIT, such as improved walking endurance, peak power, time-to-exhaustion, 
and peak oxygen consumption19,22, these interventions did not include persons with walking 
impairments. Because the HIIT interventions used in these previous studies may not be 
appropriate for those persons with MS with walking dysfunction, the examination of an acute 
HIIT exercise session for its feasibility, safety, and ability to induce a significant demand on the 
relevant physiological and functional systems for the development of a RCT is warranted. It is 
therefore important to demonstrate acutely that HIIT provides a stronger stimulus, but does not 
have deleterious effects on functional outcomes and can be enjoyable before endeavoring in a 
RCT in persons with MS who have walking dysfunction. Thus, the present study examined the 
feasibility and acute effects of a single session of HIIT exercise as compared to the CPAG 
protocol for aerobic activity using adaptive equipment on physiological and functional outcomes 
in 20 persons with MS who have mobility impairments.  
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The primary results of the current study were: 1) the HIIT exercise session significantly 
increased the physiological (i.e., W, VO2, VCO2, RER, VE, HR) and perceptual (i.e., RPE and 
leg pain) cost of exercise as compared to the CPAG session, except in the cases of core 
temperature and arm pain where there were no significant differences between conditions; 2) the 
HIIT and CPAG sessions both significantly and negatively impacted functional (i.e., 
spatiotemporal aspects of gait) and mood (e.g. total mood disturbance, fatigue, vigor, etc.) 
outcomes from pre-to-post exercise, but these decrements dissipated during the 30-minute rest 
period; 3) Cognition scores improved at each time point regardless of exercise session; and 4) the 
HIIT and CPAG sessions were feasible, safe, and equally enjoyable in persons with MS who had 
mobility impairments. These data indicate that the acute HIIT exercise session required 
significantly more work and taxed the cardiorespiratory system significantly more than the acute 
CPAG exercise session without differential consequences relative to walking, cognition, mood, 
or enjoyment outcomes. Importantly, even though the HIIT exercise session was more intense, 
and required more overall work, the HIIT exercise session was well tolerated and there were no 
untoward findings relative to the CPAG exercise session. HIIT using adaptive equipment might 
be particularly beneficial for improving fitness and functional capacity in persons with MS who 
exhibit mobility impairments and subsequent physiological deconditioning.  
The present results may support the development of an optimal HIIT exercise stimulus 
for incorporation in an exercise RCT for improving overall fitness and physiological 
conditioning in persons with MS who have mobility impairments, without deleterious effects on 
functional outcomes like walking, gait, and cognition. As stated previously, recurrent exposure to 
appropriately curated acute exercise sessions that yield preferred physiological and functional 
responses are required to stimulate the desired chronic exercise adaptations. An acute HIIT 
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prescription has been researched previously in an MS population, but was limited in its 
utilization of cycle ergometry in persons with MS with mild disability37. The present NuStep-
based, acute HIIT exercise session was identified as inducing significantly higher power output, 
oxygen uptake, carbon dioxide production, respiratory exchange ratio, minute ventilation, and 
heart rate as compared to a moderately-intense continuous exercise session in persons with 
moderate to severe MS who exhibit walking impairments. Moreover, the current data indicate no 
differential consequences relative to walking (i.e., T25FW), gait (i.e., gait velocity, cadence, step 
time, step length, base of support, and swing), and information processing speed (i.e., SDMT) in 
the HIIT condition as compared to the CPAG condition.  
Perceptually, differential effects by condition for RPE and leg pain were evident, wherein 
participants felt that they were exerting themselves more and felt more leg pain during the high-
intensity minutes and less during the recovery minutes in the HIIT session as compared to the 
corresponding time points during the CPAG session. Interestingly, there were no differential 
effects by condition for arm pain. This discrepancy between arm and leg pain is potentially 
meaningful as these data suggest that the high-intensity minutes in the HIIT session were 
probably driven by leg effort and supported only marginally by arm effort. Unfortunately, the 
current RPE measure referred to the entire body’s effort and was not differentiated by arms and 
legs as the pain outcomes were. It is important to note that overall arm and leg pain remained 
relatively low during both exercise sessions. Moreover, the main effect of condition was non-
significant for RPE, arm pain, and leg pain, suggesting that when collapsed across time, RPE, 
arm pain, and leg pain did not differ between conditions. 
Collectively, these physiological and perceptual tolerance data essentially inform the 
development of an appropriate exercise prescription for a RCT in persons with MS with mobility 
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impairments based on the ACSM’s FITT-VP principals of exercise prescription30,31. This 
intervention could utilize the current prescribed intensity (i.e., the individualized wattage 
associated with 90% of VO2peak), time (i.e., 20-minutes of active exercise with a 5-minute warm-
up and cool-down) and exercise modality type (i.e., aerobic exercise performed on a recumbent 
stepper) in combination with the FITT-VP principals of the two HIIT interventions previously 
conducted in persons with MS with mild disability19,22. To complete the ACSM’s FITT-VP 
principals of exercise prescription30,31, such an intervention might include a frequency of two-to-
three times per week, exercise volume of greater than or equal to 500-1000 MET-minutes per 
week, and a progression in exercise frequency (i.e., increasing the number of days per week of 
exercise), or intensity (i.e., increasing the prescribed wattage to be associated with 100%-120% 
of baseline VO2peak) over a 12-week period. The current results are particularly intriguing 
because they suggest that persons with mobility impairments who may be resultantly 
physiologically deconditioned could accrue critical fitness benefits as compared to traditional 
aerobic exercise in a short amount of time (i.e., three months). Indeed, the results from the 
previous cycling-based HIIT intervention in persons with MS with mild disability indicated 
significant improvements in peak power, time-to-exhaustion, peak oxygen consumption, Type II 
and Type IIa cross-sectional area, lean tissue mass, and isometric knee flexion strength over and 
above those in the continuous aerobic training group in 12 weeks of time19.  
The current data are further intriguing in that they support the development of a RCT 
from a feasibility, tolerance, and compliance perspective. Only one participant was unable to 
complete the HIIT session as prescribed, yielding a training session tolerance of 95% and 100% 
for the HIIT and CPAG exercise sessions, respectively. Further, there were no adverse events 
during the exercise sessions. Importantly, the current data indicated no differential effects by 
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condition for mood and no significant differences between the HIIT and CPAG sessions in terms 
of enjoyment. With regards to exercise adherence and enjoyment, one recent study in sedentary 
young adults identified significant increases in enjoyment following six weeks of HIIT as 
compared to moderate continuous training where steady or declines in enjoyment were 
observed132. The authors note that the increases in enjoyment for HIIT may be due to increases in 
exercise competency and strength adaptations causing subsequent increases in workload132. This 
is promising as a chronic RCT could have the potential to improve the enjoyment of HIIT in 
persons with MS with mobility impairments through increasing their familiarity with and 
proficiency for HIIT and possible increases strength outcomes. The present data indicate that 
single sessions of acute HIIT on a recumbent stepper are safe, feasible, and enjoyable without 
deleterious effects on mood.  
The primary hypothesis involved the HIIT condition inducing significantly higher and 
oscillating patterns of physiological and perceived training session tolerance data as compared to 
the relatively stable data from the CPAG exercise session. On average, participants’ oxygen 
consumption, carbon dioxide expiration, RER, VE, and HR were significantly higher during the 
HIIT session as compared to the CPAG session (Table 3, Figures 3-7). The majority of the 
physiological outcomes (i.e., carbon dioxide expiration, RER, VE, and HR) during the HIIT 
session oscillated above those from the CPAG session during both the high-intensity and 
recovery intervals. However, the pattern of oxygen consumption in the HIIT session did not 
follow an oscillating pattern as expected based on previous acute data in stroke patients28. 
Perhaps the deconditioned nature of the current participants induced an aerobic response similar 
to the post-exercise excess oxygen consumption typical at the end of an exercise session33, 
causing their oxygen use to stay elevated even during the recovery periods.  
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Interestingly, the current data did not support the hypothesis that the HIIT condition 
would induce significantly higher core temperature data as compared to the CPAG exercise 
session. Although a significant condition u time interaction effect was evident for core 
temperature, this interaction effect was likely due to minute 16, where the core temperature was 
higher in the HIIT condition than the CPAG condition (Figure 8). Core temperatures during all 
other time points appeared to be non-significantly different between the two conditions (Figure 
8). Further follow-up analyses and a non-significant main effect of condition seemed to indicate 
no significant differences between condition for core temperature. Thus, the core temperature 
data measured via ingested pills indicated significant increases in temperature during the exercise 
sessions, but temperatures did not differ based on condition. Although the some researchers 
suggest minimizing exercise intensity due to possible decrements in walking performance or 
perceived severity of symptoms with increasing temperatures84,93,94, the present data are 
encouraging as they indicate no differential effects on temperature, perceptual tolerance, or 
walking performance between the varying intensities of the HIIT and CPAG exercise conditions. 
These data further replicated previous research identifying significant increases in temperature 
from pre- to post-exercise without differential effects based on intensity22. It is important to note 
that a fan was utilized as a cooling strategy for all participants during both exercise sessions and 
may have reduced the internal temperature burden in the present sample of persons with MS84. 
As such, it is recommended that a fan is used in future studies utilizing the current HIIT and 
CPAG protocols. Overall, these data indicate that core temperature rises from pre- to post-
exercise, regardless of exercise condition, and these increases are safe and tolerable in a sample 
of persons with MS with mobility impairments.  
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The data from the perceived training session tolerance measures only partially supported 
the primary hypothesis. On average, participants rated their perceived exertion as 10.7 (2.5) and 
10.8 (3.7) for the HIIT and CPAG sessions, respectively, which equates to between “very light” 
and “light” exertion117. However, when looking at the data presented in Figure 9, it is evident 
that the HIIT RPE oscillates above and below that of the CPAG during the high-intensity and 
recovery portions of the session, respectively. These data suggest that participants perceived that 
they were working harder during the high-intensity intervals of the HIIT session and lesser 
during the recovery intervals of the HIIT session as compared to the continuous CPAG session; 
thus producing, on average similar, RPE. The data from the leg pain outcome follows the same 
pattern as RPE. However, there was no differential pattern of arm pain over time between 
conditions. Thus, the present results support the primary hypothesis for the physiological 
measures in that greater overall increases accrued in an oscillating fashion in the physiological 
(i.e., power output, oxygen consumption, carbon dioxide expiration, RER, VE, and HR) 
measures were observed during HIIT exercise as compared to CPAG. However, the primary 
hypotheses are only partially supported by the perceived training session tolerance (i.e., RPE and 
arm and leg pain) measures because the RPE and leg pain outcomes followed an oscillating 
pattern during the HIIT session, but the HIIT session did not overall induce higher RPE, arm 
pain, or leg pain.  
With regards to functional outcomes, the secondary hypothesis involved the HIIT 
condition exerting significantly larger negative effects on walking speed, gait, and cognition as 
compared to the CPAG session immediately after exercise. It was further hypothesized that these 
negative effects would rebound to baseline after the 30-minute recovery. The data do not support 
the notion that HIIT induced larger decreases as there was no significant condition u time 
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interaction on T25FW (p > .05) and only the main effect of time (p < .05) was significant for the 
spatiotemporal gait outcomes. This disparate result between the T25FW and gait velocity 
outcomes may be due to the instructions. During the T25FW, participants were instructed to 
walk “as quickly, but as safely as possible,” which may have resulted in a ceiling effect for 
participant walking speed. Participants were alternatively instructed to walk at a “normal, 
everyday pace” for the spatiotemporal gait outcomes. Thus, participants may have self-regulated 
to a slower pace when given the option to go slower than maximal during the latter outcome. 
Nonetheless, it is important to note that there were no differential consequences between 
conditions with regards to walking and gait outcomes. Only time effects were significant for 
cognition. Information processing speed increased during each subsequent trial of the SDMT, 
indicating a possible practice effect. Future research may benefit from the use of a healthy 
control group to verify this possible practice effect on cognition.  
The current study replicated previous studies identifying acute effects of HIIT on various 
physiological and functional outcomes in neurological populations36,37. Research involving acute 
HIIT exercise protocols in stroke patients identified training session tolerance ranges between 
61%-83% and significant increases in oxygen consumption (range 63.3%-70.9% VO2peak) and 
heart rate (range 63.1%-76.1% HRR)36. The present data replicate these results with 95% of 
participants successfully completing the HIIT protocol as prescribed with oxygen consumption 
and heart rate exercise intensities reaching 75.1% (9.1%) VO2peak and 82.9% (5.9%) HRpeak, 
respectively. In the acute research study involving persons with MS with mild disability, 
protocols involving continuous cycling at 60% of VO2peak and intermittent cycling at 90% 
VO2peak yielded similar increases in tympanic temperature, but higher increases in HR and leg 
and breathing RPE during the continuous cycling session as compared to the intermittent 
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session37. The present results replicate and extend these temperature data utilizing more robust 
core temperature methods with increases from 37.2 (0.5) °C pre-session to 37.7 (0.7) °C post-
session in the HIIT condition and increases from 37.2 (0.6) °C to 37.5 (0.6) °C in the CPAG 
condition. However, the current HIIT paradigm yielded significantly higher cardiorespiratory 
outcomes and heart rate as compared to the CPAG session, which is the opposite result to the 
previous acute study in persons with MS37. This discrepancy may be due to the prescribed work 
performed during each session. Total work calculations based on average power output for the 
two sessions revealed that total work was 1.4 times higher during the HIIT session as compared 
to the CPAG session. The previous study indicated that their continuous exercise session was 1.3 
times more total work37. Moreover, the current results extend these data through the addition of 
more objective cardiorespiratory measures (i.e., VCO2, RER, and VE) to better conceptualize the 
physiological nature of an acute HIIT exercise session coupled with functional outcomes, which 
identified no significant differences between conditions for the walking and gait outcomes. Thus, 
these data suggest that HIIT exercise is tolerable and capable of inducing significant changes 
physiologically in neurological populations. 
The present study further replicated and extended the literature regarding the acute effects 
of HIIT on enjoyment, RPE, and mood in neurological and healthy populations123,133. One recent 
study, analyzed the effects of continuous, light-, moderate-, and high-intensity treadmill exercise 
on mood measured via the POMS questionnaire in persons with MS with mild disability133. The 
continuous, treadmill-based moderate- and high-intensity exercise paradigms were prescribed at 
50% and 70% of heart rate reserve. The moderate-intensity session induced significant 
improvements in TMD and vigor immediately post-exercise, but these positive changes 
dissipated post-exercise. Further, neither the moderate- or high-intensity sessions impacted 
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fatigue scores. The present data indicated significant main effects for time wherein both exercise 
conditions significantly and negatively impacted TMD and fatigue; yet these mood outcomes 
subsequently returned to pre-exercise levels after 30-minutes of rest. The main effect of time was 
also significant for vigor in that both exercise sessions induced significant decreases in vigor 
post-exercise, which non-significantly rebounded after rest. The difference in TMD and vigor 
results may be due to the physiological deconditioning evident in the present population as 
compared to the previous population of persons with MS with mild disability. The current 
sample exhibited peak oxygen consumption values of 14.7 (5.2) ml/kg/min, whereas this 
previous study’s population demonstrated values of 23.5 (5.5) ml/kg/min. In the present study, 
Tension and Confusion decline at each time point, Anger was not significantly impacted, and 
Depression approached a significant decline from pre- to post-exercise. It is important to note, 
however, that the scores for these four mood outcomes were relatively low, demonstrating a 
possible floor effect. Taken together, it is evident that while moderate- to vigorous-exercise, 
continuous or interval, for persons with MS may impact different aspects of mood, specifically 
TMD, vigor, and fatigue, these changes typically dissipate following 30- to 45-minutes of rest.  
Some recent evidence has examined the relationship between RPE and enjoyment in 
recreationally active, healthy men and women123. Researchers compared RPE during single 
sessions of either acute cycling HIIT exercise or moderate-intensity, continuous exercise and 
further assessed enjoyment of each exercise session via the PACES questionnaire. The data 
indicated significantly higher enjoyment following the HIIT session as compared to the 
continuous session, despite higher RPE. The authors justified their result by asserting that the 
HIIT paradigm inherently includes: 1) recovery intervals that provide breaks from the less 
positive affective responses induced by high-intensity work; 2) a dynamic and alternating 
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stimulus; and 3) a sense of accomplishment following the completion of a HIIT session123. Thus, 
the current data indicating no differential effects of exercise condition on enjoyment coupled 
with higher perceived exertion support this recent evidence, but do not support the secondary 
hypothesis that participants would experience decreased enjoyment due to hypothesized 
increases in mood disturbance and physiological difficulty.  
The current research involved several strengths with regards to experimental design. 
Participants served as their own controls in this study’s repeated measures design, thus 
minimizing the practice effect. Order effects were further reduced through the use of a 
randomized and counter-balanced order of conditions. With regards to study outcomes, the 
present study employed multiple physiological, functional, and training session tolerance 
measures to ensure a mixture of evidence-based objective and subjective measures. One of the 
largest strengths of this study is the use of a novel approach for improving fitness in people with 
MS with mobility impairments. With the use of adaptive, aerobic exercise equipment (i.e., the 
NuStep), participants were able to tax their cardiorespiratory system to a much higher degree 
without the hindrance of safety or balance issues.  
However, the present study is not without limitations. The HIIT and CPAG exercise 
sessions were not designed on a matched-work basis. In order to match work, the CPAG session 
needed to be extended in duration, which would have increased the time burden on participants 
and decreased the ecological validity of such an exercise session. The HIIT and CPAG sessions 
were matched on exercise duration in order to meet the current CPAG and keep the time burden 
to a minimum. The current sample was close to meeting the CPAG for aerobic exercise (i.e., 3 
days per week of moderate-intensity exercise for 20 minutes) with an average aerobic exercise 
history of 2.9 days/week. This level of activity is not typical among persons with MS as only 
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20% are typically meeting public health guidelines for moderate to vigorous activity134. 
However, the sample is considered to have “very poor” aerobic fitness according to ACSM 
guidelines based on aerobic capacity30, exhibited walking impairments, and moderate disability 
with an average EDSS score of 5.8. The sample also included mostly participants with relapsing-
remitting MS (65%), but representation from persons with progressive MS was evident (35%). 
The representation of persons with progressive MS could be improved and would be beneficial 
to the literature due to the relative dearth of research involving persons with progressive MS135. 
Thus the current results may not be applicable to participants who are relatively inactive or who 
do not exhibit walking dysfunction. The study’s tailored exercise protocols should account for 
any differences, as each exercise session was prescribed based on peak aerobic capacity from the 
graded maximal exercise test performed at baseline. The lack of data regarding nutrition and 
hydration status poses another limitation to the current study. Participants were instructed to 
refrain from eating or drinking alcohol or caffeine at least three hours prior to each session but 
were otherwise instructed to maintain their “normal” dietary habits prior to each exercise session 
in order to simulate normal free-living conditions. However, compliance with these instructions 
was not assessed, and individual variability in hydration and nutrition status could affect the 
within-session physiological and perceptual tolerance outcomes. Finally, the current study’s data 
analysis did not control for age, sex, disability status, or aerobic capacity; however, the present 
study’s within-subjects, repeated measures design called for all participants to serve as their own 






Recent evidence suggests that HIIT is safe and efficacious, and perhaps superior, at 
providing benefits to persons with MS with mild disability19,22. This exercise paradigm has yet to 
be studied for its efficacy in persons with MS with walking impairments. To that end, the present 
study examined the acute effects of HIIT and continuous aerobic exercise on physiological and 
functional outcomes in persons with MS with mobility impairments as a means of identifying a 
feasible exercise prescription for providing benefits to this population. The current results 
support the viability and safety of a NuStep-based, HIIT exercise session. Further, the data 
suggest that participants exercise at a significantly higher work rate following a HIIT exercise 
session as compared to a continuous aerobic exercise session consistent with the CPAG, thus 
significantly taxing their cardiorespiratory system. Further, this enhanced physiological output 
occurs without a sustained expense to core temperature, walking, cognitive, mood, or enjoyment 
outcomes. These results are exciting because they represent the next step in developing a RCT 
utilizing HIIT for benefitting physiological and functional outcomes in persons with MS who 
have mobility impairments. Future research should implement such a RCT to identify any 





CHAPTER 7—TABLES AND FIGURES 
Table 1 
Descriptive characteristics of the sample of persons with MS (N=20).  
 
Variable Mean (SD) 
Age (years) 55.1 (7.4) 
Sex (n, % female) 17 (85%) 
Education  
High School (n, %) 1 (5%) 
Some College (n, %) 7 (35%) 
College/University Graduate (n, %) 6 (30%) 
Master’s Degree (n, %) 4 (20%) 
PhD or Equivalent (n, %) 2 (10%) 
Employment 2 (10%) 
Employed (n, %) 2 (10%) 
Unemployed (n, %) 18 (90%) 
Clinical Disease Course (n, % RRMS)  
RRMS (n, %) 13 (65%) 
Progressive MS (n, %) 7 (35%) 
Disease Duration (years) 17.2 (10.3) 
EDSS (median, interquartile range) 5.8 (0.8) 
PDDS (median, interquartile range) 4.0 (1.8) 
MSWS-12 (score) 72.1 (22.0) 
SF-36  
Physical Functioning (score) 30.0 (23.0) 
Role Functioning / Physical (score) 22.5 (33.3) 
Role Functioning / Emotional (score) 78.3 (40.9) 
Energy / Fatigue (score) 42.0 (20.4) 
Emotional Well-Being (score) 75.8 (15.9) 
Social Functioning (score) 65.6 (22.5) 
Pain (score) 59.0 (22.6) 
General Health (score) 49.0 (24.8) 
FSS (score) 5.1 (1.3) 
EXSE (score) 39.3 (26.6) 
PARQ (score) 0.6 (0.6) 
IPAQ (minutes per week of activity) 421.3 (719.0) 
GLTEQ (score) 24.5 (20.6) 
Aerobic Exercise History (days/week) 2.9 (1.2) 
VO2peak (ml/kg/min) 14.7 (5.2) 
Note. All data are presented as mean (SD) unless otherwise noted (e.g. percentages, median, etc); 
RRMS = Relapsing-Remitting Multiple Sclerosis; EDSS = Expanded Disability Status Scale; 
PDDS = Patient Determined Disease Steps; SF-36 = 36-Item Short- Form Health Survey; FSS = 
Fatigue Severity Scale; EXSE = Exercise Self-Efficacy Scale; PARQ = Physical Activity 
Readiness Questionnaire; IPAQ = International Physical Activity Questionnaire; GLTEQ = 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Study flow diagram. 
 
  Potential Participants 
Contacted (n = 67) 
  Exclusions (n = 45): 
• Never Returned Contacts (n = 28) 
• Not Interested (n = 11) 
• Unable to walk 25-feet (n = 4) 
• ≥ 2 “yes” responses on PAR-Q (n = 2) 
Enrolled (n = 22) 
Dropouts (n = 2) 
• Non-study related physical injury resulting in 
inability to walk 25-feet (n = 1) 
• Neurologist unwilling to provide approval 
and MS verification (n = 1) 
Session 1 (Baseline; n = 20) 
• Informed Consent 
• Neurological exam (EDSS) 
• T25FW 
• Spatiotemporal Gait 
• CPET 
• Questionnaires 
Sessions 2-3: HIIT 
• T1: POMS, T25FW, 
Spatiotemporal Gait, SDMT 
• HIIT Exercise Session: 
Cardiorespiratory outcomes, 
HR, Core Temperature, RPE, 
Arm & Leg Pain 
• T2: POMS, PACES, T25FW, 
Spatiotemporal Gait, SDMT 
• T3: POMS, T25FW, 
Spatiotemporal Gait, SDMT 
Sessions 2-3: CPAG 
• T1: POMS, T25FW, 
Spatiotemporal Gait, SDMT 
• CPAG Exercise Session: 
Cardiorespiratory outcomes, 
HR, Core Temperature, RPE, 
Arm & Leg Pain 
• T2: POMS, PACES, T25FW, 
Spatiotemporal Gait, SDMT 
• T3: POMS, T25FW, 




Acute effects of HIIT and CPAG NuStep-based aerobic exercise on power output, including error 



























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on relative oxygen consumption, 




























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on carbon dioxide expiration, 
























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on RER, including error bars, in 
























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on minute ventilation, including 


























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on heart rate, including error 




























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on core temperature, including 







































Acute effects of HIIT and CPAG NuStep-based aerobic exercise on RPE, including error bars, in 


























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on arm pain, including error 
































Acute effects of HIIT and CPAG NuStep-based aerobic exercise on leg pain, including error 































Acute effects of HIIT and CPAG NuStep-based aerobic exercise on walking speed, including 






















Acute effects of HIIT and CPAG NuStep-based aerobic exercise on gait velocity, including error 






























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on cadence, including error 
































Acute effects of HIIT and CPAG NuStep-based aerobic exercise on step time, including error 

























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on step length, including error 



























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on base of support, including 































Acute effects of HIIT and CPAG NuStep-based aerobic exercise on swing, including error bars, 




























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on cognitive processing speed, 


























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on total mood disturbance, 
























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on fatigue, including error bars, 





























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on vigor, including error bars, 




























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on tension, including error bars, 






























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on anger, including error bars, 




























Acute effects of HIIT and CPAG NuStep-based aerobic exercise on depression, including error 































Acute effects of HIIT and CPAG NuStep-based aerobic exercise on confusion, including error 































Acute effects of HIIT and CPAG NuStep-based aerobic exercise on enjoyment as measured by 
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